CN109481589A - 一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法 - Google Patents
一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法 Download PDFInfo
- Publication number
- CN109481589A CN109481589A CN201811298210.8A CN201811298210A CN109481589A CN 109481589 A CN109481589 A CN 109481589A CN 201811298210 A CN201811298210 A CN 201811298210A CN 109481589 A CN109481589 A CN 109481589A
- Authority
- CN
- China
- Prior art keywords
- grams
- cancer
- anticancer
- fasting
- garlic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 65
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 25
- 201000005202 lung cancer Diseases 0.000 title claims abstract description 25
- 208000020816 lung neoplasm Diseases 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000002775 capsule Substances 0.000 title claims abstract description 19
- 239000003053 toxin Substances 0.000 title claims abstract description 14
- 231100000765 toxin Toxicity 0.000 title claims abstract description 14
- 230000000694 effects Effects 0.000 claims abstract description 85
- 239000003814 drug Substances 0.000 claims abstract description 57
- 229940079593 drug Drugs 0.000 claims abstract description 37
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 17
- 240000004371 Panax ginseng Species 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 13
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 12
- 241000756943 Codonopsis Species 0.000 claims abstract description 11
- 235000020828 fasting Nutrition 0.000 claims description 98
- 206010028980 Neoplasm Diseases 0.000 claims description 91
- 235000013305 food Nutrition 0.000 claims description 80
- 201000011510 cancer Diseases 0.000 claims description 71
- 238000011282 treatment Methods 0.000 claims description 67
- TWOWSRSKGJSZHZ-VRHDFFKNSA-N bouvardin Chemical compound C1=CC(OC)=CC=C1C[C@H](N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N(C1=O)C)C2)C(=O)N[C@@H](C)C(=O)N(C)[C@H]1[C@@H](O)C(C=C1)=CC=C1OC1=CC2=CC=C1O TWOWSRSKGJSZHZ-VRHDFFKNSA-N 0.000 claims description 57
- 108010047824 bouvardin Proteins 0.000 claims description 57
- BNOCDYMCAVSRBT-UHFFFAOYSA-N bouvardin Natural products COc1ccc(CC2N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C3Cc4ccc(O)c(Oc5cccc(c5)C(O)C(N(C)C(=O)C(C)NC2=O)C(=O)N3C)c4)cc1 BNOCDYMCAVSRBT-UHFFFAOYSA-N 0.000 claims description 57
- 240000002234 Allium sativum Species 0.000 claims description 50
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 50
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 50
- 235000004611 garlic Nutrition 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 47
- 241000282414 Homo sapiens Species 0.000 claims description 43
- 230000006870 function Effects 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 238000002560 therapeutic procedure Methods 0.000 claims description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 26
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 22
- 201000010099 disease Diseases 0.000 claims description 22
- 230000036541 health Effects 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 19
- 210000002216 heart Anatomy 0.000 claims description 18
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 17
- 229920002472 Starch Polymers 0.000 claims description 17
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 17
- 210000004185 liver Anatomy 0.000 claims description 17
- 235000016709 nutrition Nutrition 0.000 claims description 17
- 239000008107 starch Substances 0.000 claims description 17
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 16
- 235000019441 ethanol Nutrition 0.000 claims description 16
- 235000013372 meat Nutrition 0.000 claims description 16
- 244000003416 Asparagus officinalis Species 0.000 claims description 15
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 15
- 240000003768 Solanum lycopersicum Species 0.000 claims description 15
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 15
- 230000006378 damage Effects 0.000 claims description 15
- 235000019698 starch Nutrition 0.000 claims description 15
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 14
- 206010006187 Breast cancer Diseases 0.000 claims description 14
- 208000026310 Breast neoplasm Diseases 0.000 claims description 14
- 206010017758 gastric cancer Diseases 0.000 claims description 14
- 239000012535 impurity Substances 0.000 claims description 14
- 230000035764 nutrition Effects 0.000 claims description 14
- 235000014347 soups Nutrition 0.000 claims description 14
- 201000011549 stomach cancer Diseases 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 13
- 235000015277 pork Nutrition 0.000 claims description 13
- 208000002193 Pain Diseases 0.000 claims description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 12
- 241000234282 Allium Species 0.000 claims description 11
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 11
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 11
- 241000234435 Lilium Species 0.000 claims description 11
- 229930003268 Vitamin C Natural products 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 11
- 229930003231 vitamin Natural products 0.000 claims description 11
- 235000013343 vitamin Nutrition 0.000 claims description 11
- 239000011782 vitamin Substances 0.000 claims description 11
- 235000019154 vitamin C Nutrition 0.000 claims description 11
- 239000011718 vitamin C Substances 0.000 claims description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 11
- 241000746966 Zizania Species 0.000 claims description 10
- 235000002636 Zizania aquatica Nutrition 0.000 claims description 10
- 241000287828 Gallus gallus Species 0.000 claims description 9
- 244000300264 Spinacia oleracea Species 0.000 claims description 9
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 9
- 208000027418 Wounds and injury Diseases 0.000 claims description 9
- 235000005686 eating Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 240000007594 Oryza sativa Species 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 8
- 230000000259 anti-tumor effect Effects 0.000 claims description 8
- 238000010411 cooking Methods 0.000 claims description 8
- 235000009566 rice Nutrition 0.000 claims description 8
- 229910052711 selenium Inorganic materials 0.000 claims description 8
- 239000011669 selenium Substances 0.000 claims description 8
- 235000011649 selenium Nutrition 0.000 claims description 8
- 241000238557 Decapoda Species 0.000 claims description 7
- 241000590002 Helicobacter pylori Species 0.000 claims description 7
- -1 black valve Substances 0.000 claims description 7
- 230000000711 cancerogenic effect Effects 0.000 claims description 7
- 238000005516 engineering process Methods 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 7
- 229940037467 helicobacter pylori Drugs 0.000 claims description 7
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 7
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 7
- 239000004223 monosodium glutamate Substances 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 210000002784 stomach Anatomy 0.000 claims description 7
- 240000007087 Apium graveolens Species 0.000 claims description 6
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 6
- 235000010591 Appio Nutrition 0.000 claims description 6
- 235000013601 eggs Nutrition 0.000 claims description 6
- 238000001727 in vivo Methods 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 230000004224 protection Effects 0.000 claims description 6
- 235000019640 taste Nutrition 0.000 claims description 6
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 5
- 244000105624 Arachis hypogaea Species 0.000 claims description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 5
- 235000018262 Arachis monticola Nutrition 0.000 claims description 5
- 208000017897 Carcinoma of esophagus Diseases 0.000 claims description 5
- 241001137251 Corvidae Species 0.000 claims description 5
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 5
- 235000012000 cholesterol Nutrition 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 230000036651 mood Effects 0.000 claims description 5
- 235000020232 peanut Nutrition 0.000 claims description 5
- 235000015108 pies Nutrition 0.000 claims description 5
- 239000008159 sesame oil Substances 0.000 claims description 5
- 235000011803 sesame oil Nutrition 0.000 claims description 5
- 235000014101 wine Nutrition 0.000 claims description 5
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 4
- 102000002322 Egg Proteins Human genes 0.000 claims description 4
- 108010000912 Egg Proteins Proteins 0.000 claims description 4
- 240000003183 Manihot esculenta Species 0.000 claims description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 4
- 235000003283 Pachira macrocarpa Nutrition 0.000 claims description 4
- 235000019483 Peanut oil Nutrition 0.000 claims description 4
- 235000014364 Trapa natans Nutrition 0.000 claims description 4
- 240000001085 Trapa natans Species 0.000 claims description 4
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 4
- 244000273928 Zingiber officinale Species 0.000 claims description 4
- 240000008866 Ziziphus nummularia Species 0.000 claims description 4
- 229940124650 anti-cancer therapies Drugs 0.000 claims description 4
- 238000011319 anticancer therapy Methods 0.000 claims description 4
- 210000004204 blood vessel Anatomy 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 235000014103 egg white Nutrition 0.000 claims description 4
- 210000000969 egg white Anatomy 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 229930003935 flavonoid Natural products 0.000 claims description 4
- 150000002215 flavonoids Chemical class 0.000 claims description 4
- 235000017173 flavonoids Nutrition 0.000 claims description 4
- 235000008397 ginger Nutrition 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 208000014674 injury Diseases 0.000 claims description 4
- 210000000936 intestine Anatomy 0.000 claims description 4
- 230000004630 mental health Effects 0.000 claims description 4
- 210000000496 pancreas Anatomy 0.000 claims description 4
- 239000000312 peanut oil Substances 0.000 claims description 4
- 235000009165 saligot Nutrition 0.000 claims description 4
- 235000013555 soy sauce Nutrition 0.000 claims description 4
- 239000013589 supplement Substances 0.000 claims description 4
- 239000011573 trace mineral Substances 0.000 claims description 4
- 235000013619 trace mineral Nutrition 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 3
- 235000011511 Diospyros Nutrition 0.000 claims description 3
- 244000236655 Diospyros kaki Species 0.000 claims description 3
- 240000004713 Pisum sativum Species 0.000 claims description 3
- 235000010582 Pisum sativum Nutrition 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 3
- 201000010881 cervical cancer Diseases 0.000 claims description 3
- 235000015203 fruit juice Nutrition 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000008274 jelly Substances 0.000 claims description 3
- 239000010985 leather Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 201000000980 schizophrenia Diseases 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 235000015192 vegetable juice Nutrition 0.000 claims description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 claims description 2
- NYNKCGWJPNZJMI-UHFFFAOYSA-N Clebopride malate Chemical compound [O-]C(=O)C(O)CC(O)=O.COC1=CC(N)=C(Cl)C=C1C(=O)NC1CC[NH+](CC=2C=CC=CC=2)CC1 NYNKCGWJPNZJMI-UHFFFAOYSA-N 0.000 claims description 2
- 244000268590 Euryale ferox Species 0.000 claims description 2
- 240000009023 Myrrhis odorata Species 0.000 claims description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 2
- 241000266501 Ormosia ormondii Species 0.000 claims description 2
- 235000014676 Phragmites communis Nutrition 0.000 claims description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 2
- 235000013087 Plumeria rubra Nutrition 0.000 claims description 2
- 244000215777 Plumeria rubra Species 0.000 claims description 2
- 241000015177 Saccharina japonica Species 0.000 claims description 2
- 208000006011 Stroke Diseases 0.000 claims description 2
- 229930003270 Vitamin B Natural products 0.000 claims description 2
- 229940124604 anti-psychotic medication Drugs 0.000 claims description 2
- 239000000935 antidepressant agent Substances 0.000 claims description 2
- 229940005513 antidepressants Drugs 0.000 claims description 2
- 238000009412 basement excavation Methods 0.000 claims description 2
- 238000001815 biotherapy Methods 0.000 claims description 2
- CJOBVZJTOIVNNF-UHFFFAOYSA-N cadmium sulfide Chemical compound [Cd]=S CJOBVZJTOIVNNF-UHFFFAOYSA-N 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000012459 cleaning agent Substances 0.000 claims description 2
- 230000019771 cognition Effects 0.000 claims description 2
- 239000000571 coke Substances 0.000 claims description 2
- 235000013409 condiments Nutrition 0.000 claims description 2
- 238000007596 consolidation process Methods 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 238000002224 dissection Methods 0.000 claims description 2
- 210000000750 endocrine system Anatomy 0.000 claims description 2
- 238000004146 energy storage Methods 0.000 claims description 2
- 210000003238 esophagus Anatomy 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 238000001879 gelation Methods 0.000 claims description 2
- 230000005484 gravity Effects 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 230000000147 hypnotic effect Effects 0.000 claims description 2
- 208000032839 leukemia Diseases 0.000 claims description 2
- 230000033001 locomotion Effects 0.000 claims description 2
- 238000002803 maceration Methods 0.000 claims description 2
- 210000005075 mammary gland Anatomy 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 235000021049 nutrient content Nutrition 0.000 claims description 2
- 235000021395 porridge Nutrition 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 2
- 230000008093 supporting effect Effects 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 210000001685 thyroid gland Anatomy 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 235000019156 vitamin B Nutrition 0.000 claims description 2
- 239000011720 vitamin B Substances 0.000 claims description 2
- 239000011800 void material Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 claims 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 claims 1
- 229930003448 Vitamin K Natural products 0.000 claims 1
- 230000001112 coagulating effect Effects 0.000 claims 1
- 201000010175 gallbladder cancer Diseases 0.000 claims 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims 1
- 201000001514 prostate carcinoma Diseases 0.000 claims 1
- 235000019168 vitamin K Nutrition 0.000 claims 1
- 239000011712 vitamin K Substances 0.000 claims 1
- 150000003721 vitamin K derivatives Chemical class 0.000 claims 1
- 229940046010 vitamin k Drugs 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 43
- 210000004369 blood Anatomy 0.000 abstract description 42
- 206010030113 Oedema Diseases 0.000 abstract description 8
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 231100000614 poison Toxicity 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 7
- 230000002588 toxic effect Effects 0.000 abstract description 7
- 230000001939 inductive effect Effects 0.000 abstract description 6
- 239000002574 poison Substances 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 4
- 206010036790 Productive cough Diseases 0.000 abstract description 3
- 210000003802 sputum Anatomy 0.000 abstract description 3
- 208000024794 sputum Diseases 0.000 abstract description 3
- 210000003205 muscle Anatomy 0.000 abstract 1
- 240000002900 Arthrospira platensis Species 0.000 description 43
- 235000016425 Arthrospira platensis Nutrition 0.000 description 42
- 229940082787 spirulina Drugs 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 36
- 238000011160 research Methods 0.000 description 25
- 108090000623 proteins and genes Proteins 0.000 description 19
- 235000005911 diet Nutrition 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- 235000013361 beverage Nutrition 0.000 description 16
- 235000013399 edible fruits Nutrition 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 16
- 235000010081 allicin Nutrition 0.000 description 15
- 230000012010 growth Effects 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 15
- 235000013311 vegetables Nutrition 0.000 description 15
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 14
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 14
- 230000037213 diet Effects 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 150000002632 lipids Chemical class 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 230000001976 improved effect Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000009286 beneficial effect Effects 0.000 description 10
- 230000003115 biocidal effect Effects 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 10
- 230000002265 prevention Effects 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 230000001684 chronic effect Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000036737 immune function Effects 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000036039 immunity Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 210000004881 tumor cell Anatomy 0.000 description 8
- 206010009944 Colon cancer Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 7
- 241000195493 Cryptophyta Species 0.000 description 7
- 241001313708 Dictyophora phalloidea Species 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 238000009395 breeding Methods 0.000 description 7
- 230000001488 breeding effect Effects 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 201000007270 liver cancer Diseases 0.000 description 7
- 208000014018 liver neoplasm Diseases 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- 235000008935 nutritious Nutrition 0.000 description 7
- 238000010926 purge Methods 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 240000007124 Brassica oleracea Species 0.000 description 6
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 6
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 6
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 241000233866 Fungi Species 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 235000007710 Grifola frondosa Nutrition 0.000 description 6
- 240000001080 Grifola frondosa Species 0.000 description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 241000121220 Tricholoma matsutake Species 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 235000013325 dietary fiber Nutrition 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 210000000987 immune system Anatomy 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000001603 reducing effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 235000016623 Fragaria vesca Nutrition 0.000 description 5
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 5
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 5
- 206010033307 Overweight Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 229960000890 hydrocortisone Drugs 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 201000002313 intestinal cancer Diseases 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 4
- 244000189799 Asimina triloba Species 0.000 description 4
- 235000006264 Asimina triloba Nutrition 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 4
- 201000009030 Carcinoma Diseases 0.000 description 4
- 235000009467 Carica papaya Nutrition 0.000 description 4
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 4
- 241001313734 Dictyophora Species 0.000 description 4
- 102400001368 Epidermal growth factor Human genes 0.000 description 4
- 101800003838 Epidermal growth factor Proteins 0.000 description 4
- 240000009088 Fragaria x ananassa Species 0.000 description 4
- 241000222684 Grifola Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 244000017020 Ipomoea batatas Species 0.000 description 4
- 235000002678 Ipomoea batatas Nutrition 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 4
- 241000237502 Ostreidae Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000006838 adverse reaction Effects 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 235000015895 biscuits Nutrition 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 231100000357 carcinogen Toxicity 0.000 description 4
- 239000003183 carcinogenic agent Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 206010009887 colitis Diseases 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229940116977 epidermal growth factor Drugs 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 235000020636 oyster Nutrition 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 208000016261 weight loss Diseases 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010005003 Bladder cancer Diseases 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 3
- 240000008397 Ganoderma lucidum Species 0.000 description 3
- 208000012895 Gastric disease Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010027439 Metal poisoning Diseases 0.000 description 3
- 244000302512 Momordica charantia Species 0.000 description 3
- 235000009811 Momordica charantia Nutrition 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 3
- 208000008469 Peptic Ulcer Diseases 0.000 description 3
- 244000088415 Raphanus sativus Species 0.000 description 3
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 206010039491 Sarcoma Diseases 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 230000003288 anthiarrhythmic effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 235000021168 barbecue Nutrition 0.000 description 3
- 235000013527 bean curd Nutrition 0.000 description 3
- 235000013405 beer Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 231100000315 carcinogenic Toxicity 0.000 description 3
- 208000019065 cervical carcinoma Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 235000001497 healthy food Nutrition 0.000 description 3
- 235000015243 ice cream Nutrition 0.000 description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 208000008127 lead poisoning Diseases 0.000 description 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000001671 psychotherapy Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 208000018556 stomach disease Diseases 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 201000005112 urinary bladder cancer Diseases 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 241000272525 Anas platyrhynchos Species 0.000 description 2
- 241000272814 Anser sp. Species 0.000 description 2
- 206010003225 Arteriospasm coronary Diseases 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 2
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 2
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 2
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 2
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 2
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- 235000004936 Bromus mango Nutrition 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000011305 Capsella bursa pastoris Nutrition 0.000 description 2
- 240000008867 Capsella bursa-pastoris Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 244000234623 Coprinus comatus Species 0.000 description 2
- 235000004439 Coprinus comatus Nutrition 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- 241000223935 Cryptosporidium Species 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 230000010190 G1 phase Effects 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 208000019637 Infantile Diarrhea Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- 102000016267 Leptin Human genes 0.000 description 2
- 108010092277 Leptin Proteins 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical class [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 235000014826 Mangifera indica Nutrition 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 2
- 235000018365 Momordica dioica Nutrition 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 235000014528 Pholiota nameko Nutrition 0.000 description 2
- 244000168667 Pholiota nameko Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- 241001486992 Taiwanofungus camphoratus Species 0.000 description 2
- 108010017842 Telomerase Proteins 0.000 description 2
- 241001088563 Trichotoma Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 239000003416 antiarrhythmic agent Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 238000010322 bone marrow transplantation Methods 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 208000022371 chronic pain syndrome Diseases 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000004578 fetal growth Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 2
- 229940039781 leptin Drugs 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- 208000025036 lymphosarcoma Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 235000020830 overeating Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 235000021017 pears Nutrition 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 235000015136 pumpkin Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 201000010727 rectal prolapse Diseases 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 235000020097 white wine Nutrition 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 235000016804 zinc Nutrition 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- MUCOHWBULSBLLZ-LSUAHRBSSA-N (3R,4S,5S,6R)-2-[(3S,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E)-2-hydroxy-25-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-2,6,10,14,19,23-hexamethylpentacosa-4,6,8,10,12,14,16,18,20,22,24-undecaen-3-yl]oxy-6-methyloxane-3,4,5-triol Chemical compound C[C@H]1OC(O[C@@H](\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)O)[C@H](O)[C@@H](O)[C@@H]1O MUCOHWBULSBLLZ-LSUAHRBSSA-N 0.000 description 1
- IXELFRRANAOWSF-FNORWQNLSA-N (E)-Ajoene Chemical compound C=CCSS\C=C\CS(=O)CC=C IXELFRRANAOWSF-FNORWQNLSA-N 0.000 description 1
- RHUYHJGZWVXEHW-UHFFFAOYSA-N 1,1-Dimethyhydrazine Chemical compound CN(C)N RHUYHJGZWVXEHW-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- CKUVNOCSBYYHIS-LGYUXIIVSA-N 20(R)-Ginsenoside Rh2 Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1C(C)(C)[C@H]2[C@@](C)([C@H]3[C@](C)([C@@]4(C)[C@H]([C@H](O)C3)[C@@H]([C@](O)(CC/C=C(\C)/C)C)CC4)CC2)CC1 CKUVNOCSBYYHIS-LGYUXIIVSA-N 0.000 description 1
- AWGBKZRMLNVLAF-UHFFFAOYSA-N 3,5-dibromo-n,2-dihydroxybenzamide Chemical compound ONC(=O)C1=CC(Br)=CC(Br)=C1O AWGBKZRMLNVLAF-UHFFFAOYSA-N 0.000 description 1
- VJFMSYZSFUWQPZ-BIPCEHGGSA-N 4-[(r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-hydroxymethyl]quinolin-6-ol Chemical compound C1=C(O)C=C2C([C@H]([C@H]3N4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 VJFMSYZSFUWQPZ-BIPCEHGGSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000252082 Anguilla anguilla Species 0.000 description 1
- 208000000103 Anorexia Nervosa Diseases 0.000 description 1
- 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
- 102100040214 Apolipoprotein(a) Human genes 0.000 description 1
- 101710115418 Apolipoprotein(a) Proteins 0.000 description 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N Arsenious Acid Chemical compound O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 description 1
- 241000234427 Asparagus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 244000026811 Brassica nipposinica Species 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 244000064816 Brassica oleracea var. acephala Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 241000386927 Cinnamomum micranthum f. kanehirae Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000016918 Complement C3 Human genes 0.000 description 1
- 108010028780 Complement C3 Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 241000732800 Cymbidium Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 208000014260 Fungal keratitis Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 241000427324 Glinus Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 206010073069 Hepatic cancer Diseases 0.000 description 1
- 240000000588 Hericium erinaceus Species 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010067997 Iodine deficiency Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 208000019428 Ligament disease Diseases 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101000869659 Mus musculus Relaxin receptor 2 Proteins 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- MUCOHWBULSBLLZ-UHFFFAOYSA-N Myxoxanthophyll Natural products OC1C(O)C(O)C(C)OC1OC(C(C)(C)O)C=CC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(O)CC1(C)C MUCOHWBULSBLLZ-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- DCTLJGWMHPGCOS-UHFFFAOYSA-N Osajin Chemical compound C1=2C=CC(C)(C)OC=2C(CC=C(C)C)=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DCTLJGWMHPGCOS-UHFFFAOYSA-N 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 240000002690 Passiflora mixta Species 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000722337 Pholiota Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010010522 Phycobilisomes Proteins 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000004292 Pistacia texana Nutrition 0.000 description 1
- 244000289433 Pistacia texana Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- OUZCFMSJGDEXRT-UHFFFAOYSA-N Scandinone Natural products O=C1C=2C(OC)=C(CC=C(C)C)C=3OC(C)(C)C=CC=3C=2OC=C1C1=CC=C(O)C=C1 OUZCFMSJGDEXRT-UHFFFAOYSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000489998 Streptanthus tortuosus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 241000223997 Toxoplasma gondii Species 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 208000007814 Unstable Angina Diseases 0.000 description 1
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 208000037842 advanced-stage tumor Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- IXELFRRANAOWSF-CYBMUJFWSA-N ajoene Natural products C=CCSSC=CC[S@](=O)CC=C IXELFRRANAOWSF-CYBMUJFWSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 201000011068 alcoholic psychosis Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002946 anti-pancreatic effect Effects 0.000 description 1
- 230000000884 anti-protozoa Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940125708 antidiabetic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000003532 cataractogenesis Effects 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 210000004970 cd4 cell Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- IXELFRRANAOWSF-UHFFFAOYSA-N cis-ajoene Natural products C=CCSSC=CCS(=O)CC=C IXELFRRANAOWSF-UHFFFAOYSA-N 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000007784 diverticulitis Diseases 0.000 description 1
- 235000015177 dried meat Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000037024 effective refractory period Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229930000755 gossypol Natural products 0.000 description 1
- 229950005277 gossypol Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical group C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 208000024697 human cytomegalovirus infection Diseases 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 206010022498 insulinoma Diseases 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 235000006479 iodine deficiency Nutrition 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 108700011006 mouse mighty Proteins 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 230000009907 neuroendocrine response Effects 0.000 description 1
- 210000000607 neurosecretory system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000020925 non fasting Nutrition 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 208000021255 pancreatic insulinoma Diseases 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002306 phycobilisome Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000021460 special beverage Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 210000000059 tachyzoite Anatomy 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- AODPIQQILQLWGS-GXBDJPPSSA-N tetrahydrocortisol Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CC[C@@H]21 AODPIQQILQLWGS-GXBDJPPSSA-N 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 235000020023 weizenbier Nutrition 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 235000020019 witbier Nutrition 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/10—Meat meal or powder; Granules, agglomerates or flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/20—Meat products; Meat meal; Preparation or treatment thereof from offal, e.g. rinds, skins, marrow, tripes, feet, ears or snouts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/40—Shell-fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/03—Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/20—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof consisting of whole seeds or seed fragments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/20—Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
- A23P20/25—Filling or stuffing cored food pieces, e.g. combined with coring or making cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Abstract
本发明公开了一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法,它是由西洋参、高丽参、党参、丹参、赤芍、当归、川芎等药物进行组合制备的,本发明药物具有清热凉血,补中益气,利水消肿,散结化痰,解毒生肌的功能,用于治疗肺癌疗效快,无毒副作用。
Description
技术领域
本发明涉及一种治疗肺癌的药物,属中药领域。
背景技术
肺癌是为最常见的恶性肿瘤之一,是肿瘤的死亡之首,一经发现即为中晚期,西医治疗多以对症用药为主,只能对病灶进行局部缓解或治疗,治标而不治本。金盾出版社2000年12月修订第7次印刷发行的《肺癌防治》一书中介绍了雄黄、硇砂、砒石、轻粉等金石矿物类药物以毒攻毒的中医学说,用于止痛或辅助治疗已初见成效,但都无法达到治愈或根除的效果,而且还隐藏着诸多的毒副作用。
发明内容
因此,人们对疗效更好的中药及食疗存在极大的需求,至今为止还没有发现任何关于本发明药物的有关报道,本发明人根据中药理论的研究及临床试验的反复验证,终于成功的研制出治疗肺癌的排毒抗癌胶囊,从而完成了本发明。
本发明的目的就是提供一种治疗肺癌的排毒抗癌胶囊及食疗疗法。
本发明的另一个目的就是提供了该排毒抗癌胶囊的制备方法。
一、药物治疗
本发明药物是选择西洋参、高丽参、党参、丹参、赤芍、当归、川芎、黄芪、百合、山兹姑、芦笋进行组合制备的,将这些药物组合,使得各药物功效产生协同作用,从而能够有效治疗肺癌的复发。其中选用西洋参是因为其性味甘微苦,凉,入心、肺、肾三经,有益肺阴,清虚火,生津止渴的功能,治肺虚久嗽,失血,咽干口渴,虚热烦倦。选用高丽参,别名别直参、红参,其性味甘、微苦,温,归脾、肺、心经,有大补元气,复脉固脱,益气摄血的功能,治体虚欲脱,肢冷脉微,气不摄血,崩漏下血,心力衰竭,心源性休克。选用党参是因为其性味甘,平,入手、足太阴经气分,有补中益气,生津的功能,治脾胃虚弱,气血两亏,体倦无力,食少,口渴,久泻,脱肛。选用丹参是因为其性味苦,微温,入心、肝经,有活血去瘀,安神宁心,排脓,止痛的功能,治心绞痛,月经不调,痛经,以闭,血崩带下,癥瘕,积聚,瘀血腹痛,骨节疼痛,惊悸不眠,恶疮肿毒。选用赤芍是因为其性味苦,微寒,归肝经,有清热凉血,散瘀止痛的功能,治温毒发狂,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,癎瘕腹痛,跌扑损伤,痈肿疮疡。选用当归是因为其性味甘辛,温,入心、肝、脾经,有补血和血,调经止痛,润燥滑肠的功能,治月经不调,经闭腹痛,癥瘕结聚,崩漏,血虚头痛,眩晕,痿痹,肠燥难便,赤痢后重,痈疽疮疡,金疮,跌扑损伤。选用川芎是因为其性味辛,温,入肝、胆经,有行气开郁,祛风燥湿,活血止痛的功能,治风冷头痛旋晕,胁痛腹疼,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡。选用黄芪是因为其性味甘,微温,入肺、脾经,生用有益卫固表,利水消肿,托毒,生肌的功能,治自汗,盗汗,血痹,浮肿,痈疽不溃或溃久敛;炙用有补中益气的功能,治内伤劳倦,脾虚泄泻,脱肛,气虚血脱,崩带及一切气衰血虚之症。选用百合是因为其性味甘微苦,平,入心、肺经,有润肺止咳,清心安神的功能,治肺痨久嗽,咳唾痰血,热病后余热未清,虚烦惊悸,神志恍惚,脚气浮肿。选用山兹姑是因为其性味甘微辛,寒,入肝、脾经,有消肿,散结,化痰,解毒的功能,治痈疽疔肿,瘰疬,喉痹肿痛,蛇、虫、狂、犬伤。选用芦笋是因为其性味小苦,治热病口渴,淋病,小便不利。
本发明药物组分的用量也是发明人经过反复的试验摸索得来的,各组分的用量在下述重量范围内都具有较好的疗效:
西洋参 40-60克 高丽参 40-60克 党 参 40-60克
丹 参 40-60克 赤 芍 40-60克 当 归 40-60克
川 芎 40-60克 黄 芪 80-120克 百 合 80-120克
山兹姑 80-120克 芦 笋 150-250克。
优选用量为
西洋参 50克 高丽参 50克 党 参 50克
丹 参 50克 赤 芍 50克 当 归 50克
川 芎 50克 黄 芪 100克 百 合 100克
山兹姑 100克 芦 笋 200克。
本发明的制备方法如下:
(一)备料
1、西洋参:原药用清水喷潮,覆盖湿布,夏秋润2天,冬春润3天,取出切片,晾干;
2、高丽参:取原药材,润透,切薄片,干燥;
3、党参:洗净泥沙后润透去芦,切片或切段,晒干;
4、丹参:拣净杂质,除去根茎,洗净,捞出,润透后切片,晾干;
5、赤芍:取原药材,除去杂质,大小分档,洗净,润透,切薄片,干燥,筛去碎屑;
6、当归:拣去杂质,洗净,闷润,稍晾,切片晒干;
7、川芎:拣去杂质,分开大、小个,用水浸泡,晒晾,闷润后切片,干燥;
8、黄芪:拣净杂质,除去残留的根头和空心较大的根,用水浸泡,捞出,润透后及时切片,晒干;
9、百合:拣去杂质,黑瓣,簸除灰屑;
10、山兹姑:除去须根,洗净,清水浸泡2-4小时,取出润透,切片,晒干;
11、芦笋:春、夏采挖,晒干。
(二)制备
1、将炮制好的西洋参、高丽参、党参、丹参、赤芍、当归、川芎、黄芪、百合、山兹姑、芦笋放入煎药容器内加水煎煮二次,第一次加水8 倍量,煎煮1.5 小时,第二次加水6 倍量煎煮1 小时,合并两次煎煮液,过滤得滤液;
2、将滤液浓缩成比重为1.35 的浸膏,加90%-95% 乙醇进行醇沉,回收乙醇并浓缩,在45-50℃下干燥,制得干浸膏;
3、将干浸膏粉碎成粉,装入胶囊。
组方中西洋参有益肺阴,清虚火,生津止渴的功能为君药;黄芪利水消肿,托毒生肌;百合有润肺止咳,清心安神的功能,二者为臣药,三味药共同发挥清火生津,利水消肿,托毒生肌,清心润肺的作用,且以利水消肿,托毒生肌为主可治本;山兹姑消肿散结,化痰解毒为佐药;赤芍有清热凉血,散瘀止痛的功能为使药,与下余诸药是治标。
本发明药物具有清热凉血,补中益气,利水消肿,散结化痰,补血和血,托毒生肌,益肺阴,清虚火,解毒生津的功能,用于治疗肺癌见效快,无毒副作用。
二、饮食疗法
饮食与肿瘤有着千丝万缕的关系,吃错了会引爆癌症的导火索,吃对了则能起到防癌的功效。适当的食物确有治病、防病之功效,例如蛋白质、锌、维生素C和E,人参皂苷rh2等等,这些营养都有助于巩固我们的免疫系统。免疫系统十分脆弱,它不像心脏和循环系统那样坚强。西谚有云:一日一苹果,病毒远离我。
皮肤的免疫系统包含一系列的复杂屏障,防范病毒的侵犯。举例说,皮肤、鼻孔和肺里的粘膜粘液是我们身体的第一道防线,抵抗细菌和病毒的侵袭。在精神上备受压力或营养不良时期,我们的免疫系统会变弱,如维生素A不足,肺部粘膜功能减弱,让细菌和病毒肆无忌惮地进犯身体。基本上,人的免疫系统越壮抵抗传染的防护越坚强,如果生病或受伤,也会比免疫能力低的人快些复原。以下就是一些既能够保证刺激人们的味蕾,又能增强人体健康的食品。
(1)西兰花和卷心菜:十字花科植物,包括西兰花、卷心菜、椰菜花、芽甘蓝,都是抗癌的食物。很多研究显示,常吃上述蔬菜可减少胃癌、乳癌、肠癌的威胁。令人惊异的是,十字花科蔬菜里的治病物质既非维生素,又非矿物质,而是一系列被称为靛基质的复合物。但靛基质会在煮的时候失去,所以不要煮的时间太长。(2)柑橘橙类水果:除了青椒、木瓜外,柑橘橙类水果充满维生素C,都是防止白内障形成的最佳方法。因为白内障的形成,是眼球晶状体因吸烟和空气污染及长年氧化所致。维生素C帮助阻止氧化引致的损害。事实上,一项近期研究显示,每日多吃过三餐水果和蔬菜,患上白内障的危险会减低百分之二十。维生素C亦能提高细胞的免疫能力。
前不久,世界卫生组织经过3年的研究和“评选”发布了一张榜单,虽然这是一张食品榜,但它揭示出的六种最健康食品和十大垃圾食品,相信一定会比时尚流行榜更受你的关注。在3年的时间里,世界卫生组织对人们日常饮食中涉及的各种食品都进行了分析和研究,评选出了最佳蔬菜、最佳水果、最佳肉食、最佳食油、最佳汤食、最佳护脑食品等6种最健康食品。同时,油炸食品、腌制食品、加工肉食、饼干、碳酸饮料、方便食品、罐头、果脯、冷冻甜品及烧烤食品等也“入选”了Top10垃圾食品。那么,这些健康食品究竟对人们有什么好处,垃圾食品是不是一点都不能吃,又该怎么吃。为此,记者走访了多位营养学家。抗癌无色营养早在2000年前,《黄帝内经》就有一句名言;“谷肉果菜,食养尽之。”这是说,治疗病症不仅要靠药物,还要配合饮食调养。癌症是一种慢性的消耗性疾病,会耗掉人体的营养,时间一长,病人就会营养不良,晚期的癌症病人更为突出,越来越消瘦,中医称为“失荣”,西医称为“恶病质”。所以,无论早期或者晚期的癌症病人,都要想办法得到全面的营养供给。除了补充谷肉果蔬外,一种以“无色营养”著称的物质可以更全面的给癌症病人给予供给。“无色营养”自然因子,生态级负离子能够透过人体血脑屏障,发挥其生物活性。临床试验证明:人体细胞电子被抢夺是万病之源,活性氧(自由基ORS)是一种缺乏电子的物质(不饱和电子物质),进入人体后到处争夺电子,如果夺去细胞蛋白分子的电子,使蛋白质接上支链发生烷基化,形成畸变的分子而致癌。这样,恶性循环就会形成大量畸变的蛋白分子,这些畸变的蛋白分子繁殖复制时,基因突变。形成大量癌细胞,最后出现癌症。而当自由基或畸变分子抢夺了基因的电子时,人就会直接得癌症。人体得到小粒径负离子后,由于小粒径负离子带负电有多余的电子,可提供大量电子,而阻断恶性循环,癌细胞就可防止或被抑制。抗癌食品分类益于男性健康抗癌食品西红柿:男性经常食用熟西红柿能降低前列腺发病率45%,这是因为西红柿中含有番茄红素、维生素C、维生素E、硒、膳食纤维等。吸烟时,有抗癌功效的β-胡萝卜素的结构都会发生变化,而番茄红素却会保持不变。香菇:对于经常饮酒又不胜酒力的男性而言,多吃香菇对肝脏具有较好的保护作用。因为香菇含有一种特殊的物质葡聚糖。
(2)牡蛎:锌不足会造成精子数降低、睾丸素分泌减少。而牡蛎所含的锌是鸡蛋的30倍,因此,备受压力折磨的男性可以多吃些牡蛎。牡蛎所含的糖原还能使男性经性生活产生的疲劳得以迅速缓解。益于女性健康抗癌食品花椰菜:花椰菜所含的维生素C是柠檬的2倍;每100克花椰菜含铁1.9毫克;所含的萝卜硫素能消灭幽门螺旋杆菌;所含的I3C是一种能抗癌的天然物质,能影响雌激素的新陈代谢,预防乳癌等;I3C还能有效抑制人乳头状瘤病毒,这种病毒是引发宫颈癌的原凶之一。
(3)黄豆:黄豆富含的异黄酮类,研究证实,这种物质能预防乳癌和骨质疏松,并减轻女性更年期综合征。半流质食品运用中医八法中的“和法”的产物,长效温和的对抗癌症,以健脾护胃,护肝肾、解毒为主,辅以清肺养心,调顺六腑,全面调理人体免疫机能的功能,达到抑制肿瘤,减轻治疗反应,预防转移复发的目地。健康食品蔬菜类胡萝卜:富含维生素A、B2、B5、蔗糖、葡萄糖、淀粉、钙、铁、磷等微量元素,尤其是吸烟的人摄入较多的维生素A,可减少患肺癌的机会,是抵抗癌症的理想食品。缺乏维生素A者,癌症的发生率是正常人的两倍多。黄豆:富含蛋白质,氨基酸的组成齐全,并含铁多。富含抗癌的微量元素。经常食用黄豆汤、豆浆、豆腐、豆腐干,能防癌抗癌。
(4)大蒜:富含蒜素和硒等微量元素,经常食用有防癌、抗癌、杀菌、抗菌作用。大蒜有“地里长出的青霉素”之称,西兰花和卷心菜:十字花科的植物,包括西兰花、卷心菜、椰菜花、芽甘蓝,都是抗癌的食物。很多研究显示,常吃上述蔬菜可减少胃癌、乳癌、肠癌的威胁。令人惊异的是,十字花科蔬菜里的治病物质既非维生素,又非矿物质,而是一系列被称为靛基质的复合物。但靛基质会在煮的时候失去,所以不要煮得时间太长。
(5)山楂能活血化瘀、化滞消积、开胃消食,同时还含有丰富的维生素C.中医认为,癌瘤为实性肿块,往往具有气滞血瘀征象,由于山楂能活血化淤、善消肉积,又能抑制癌细胞的生长,所以适宜多种癌瘤患者的治疗。尤其是对消化道和妇女生殖系统恶性肿瘤患者兼有食欲不振时更为适宜。
(6)无花果能消肿解毒,适宜大肠癌、食道癌、膀胱癌、胃癌、肺癌、肝癌、乳腺癌、白血病、淋巴肉瘤等多种癌症患者食用,是一种广谱抗癌果品。据现代药理研究表明,无花果的确有良好的抗癌功效。据报道:干果的水提取物有抗艾氏肉瘤的作用。从未成熟的果实中所得到的乳汁能抑制大鼠移植性肉瘤、小鼠自发性乳癌,致使肿瘤坏死;又能延缓移植性腺癌、骨髓性白血病、淋巴肉瘤之发展,使其退化。
(7)红薯:红薯里含有丰富的纤维、钾、铁和维生素B6,不仅能防止衰老、预防动脉硬化,还是抗癌能手,所以它被选为蔬菜之首。苦瓜:苦瓜的抗癌功效来自一种类奎宁蛋白,它是一种能激活免疫细胞的活性蛋白,通过免疫细胞做“二传手”,将癌细胞或其他不正常的细胞杀掉。苦瓜种子中含有一种蛋白酶抑制剂,能抑制肿瘤细胞分泌蛋白酶,从而抑制癌细胞的侵袭和转移。除了上面提到的几种蔬菜,芦笋、花椰菜、茄子、甜菜、荠菜、苤蓝菜、金针菇、雪里红、大白菜也要记得多吃。
(8)菌菇类例举具有代表性的几种:竹荪(菌中皇后)竹荪中所含的竹荪多糖具有一定的清除超氧阴离子自由基作用,可抑制人体细胞膜的脂质过氧化,是其抗肿瘤、提高免疫力的主要作用机理之一。竹荪多糖可显著提高机体巨噬细胞的吞噬指数,并可刺激抗体的产生,从而增强人体的免疫功能。竹荪多糖对癌细胞具有很强的抑制作用,具有抗肿瘤活性。据报道国外已开始将竹荪多糖,作为原发性肝癌等恶性肿瘤的辅助治疗药物,用于二期临床,结果显示具有不同程度的抗癌活性。此外竹荪还含有丰富的膳食纤维,其不溶性膳食纤维更高达28%以上。膳食纤维还能促使多种致癌物随粪便一起排出,降低致癌物的浓度。竹荪中的膳食纤维可改善肠内菌群,使双歧杆菌等有益菌活化繁殖,从而抑制肠内有害菌的繁殖,并吸收有害菌所产生的二甲基联氨等致癌物质。资料表明,竹荪中的膳食纤维可降低大肠癌、结肠癌、乳腺癌、胃癌、食管癌等癌症的发生。竹荪富微量元素硒,硒是人体不可缺少的微量元素,硒营养与机体免疫功能、抗氧化能力、抗癌作用等密切相关。通过对硒的生理功能的研究得知,适当增加对硒的摄入量,对预防肿瘤等疾病的发生具有重要意义。云南苗族人患癌症的几率较低,这恐怕与他们经常用竹荪与糯米一同泡水食用有关。
灰树花(舞茸)灰树花又叫莲花菌、贝叶多孔菌,也叫舞茸。是一种名贵的药食两用菌。药理试验表明:灰树花有提高机体产生干扰素、抑制病毒生长、提高免疫功能、抑制肿瘤等疗效。其灰树花多糖是一种理想的生物反应调节剂,促进产生更多T淋巴细胞,促进B细胞的有丝分裂,提高NK细胞活性,增加巨噬细胞的C3补体的释放量,从而显著地提高机体免疫功能。灰树花具有抗癌、抑制感冒病毒、单纯疱疹病毒、各类肝炎病毒的复制和繁殖,并有抗高血压、降血糖和血脂的作用。美国乔治城大学HARRY PREUSS 教授和纽约医科大学SENSUKE KONNO教授在165篇有关舞茸研究文献的基础上,在他们出版的《Maitake Magic》(《舞茸神奇功效》)一书中,将舞茸的作用总结为以下几个方面:①激活人体免疫系统;②抑制癌细胞的生长和扩散;③使正常细胞免受致癌物质的破坏;④减轻放化疗的副作用;⑤通过增强人体免疫力防止细菌和病毒感染;⑥防止AIDS患者体内CD4细胞减少;⑦有助于抑制HⅣ的增殖;⑧减轻HⅣ/AIDS患者的感染症状;⑨维持正常人体正常血糖水平和胰岛素功能;⑩降低高血压和胆固醇。松茸(松口蘑)松茸又称为松口蘑,是醇香味物质,有很高的营养价值。除食用外,还有药用价值。科学研究发现松茸具有增强机体免疫、强身、益肠胃、止痛、理气化痰、驱虫等医药功效;还可治疗手足麻木、腰酸腿痛、尿浊不禁等症。改善更年期内分泌紊乱、性功能失调等作用。所以有松茸赛鹿茸之说。现代医学研究表明还有治疗糖尿病,抗癌的效果。滑菇又叫光帽鳞伞、珍珠菇,属于鳞伞属。滑菇是一种低热量、低脂肪的保健食品。滑菇不仅味道鲜美,营养丰富。而且附着在滑菇菌伞表面的粘性物质是一种核酸,对肿瘤有明显的抑制作用,并对保持人体的精力和脑力大有很大益处。毛头鬼伞(鸡腿蘑)鸡腿菇是一种传统食用菌,有着很高的药用价值,不但民间常用以治疗糖尿病、降血压,现代药理研究发现它有提高免疫力及抗肿瘤的明显功效,对肺癌和腹水癌细胞的抑制率很高。另外,它还有改善心律,提高心血输出量的作用。常食用,口渴、多尿、目眩、腰酸症状也能得到改善。
香菇:香菇是一种著名的药食两用菌。医药研究发现,香菇有调节T淋巴细胞数量、促进抗体形成、活化巨噬细胞、诱导产生干扰素、抗病毒、抗肿瘤、治肝炎、降血压、降血脂,预防黏膜炎、皮肤炎、肝硬化、血管硬化等疗效。云芝:云芝又叫彩云革盖菌。云芝具有保肝利胆的功能,并具有人体免疫调节作用、止痛、抗氧化、抑制肿瘤生长,修复人体受损细胞,并具有清热消炎、治疗慢性气管炎的功能。灵芝是一种著名的药食两用菌。
医药研究证实,灵芝具有多方面的治疗作用,能提高人体生命力、提高心血管功能、提高免疫功能,在治疗神经衰弱、冠心病、糖尿病、哮喘、肝炎、慢性支气管炎、肿瘤疾病方面发挥了良好的作用。猴头菇:它属真菌类食品,能利五脏、助消化,常食能增强肌体免疫力,延缓衰老,从中提取的多肽类物质,对消化系统的癌肿有抑制作用,并能改善人体健康状况。牛樟芝:又名牛樟菇,台湾珍贵的药用真菌,仅生长于台湾特有的牛樟树上,牛樟芝含有多种活性成分,有效成分中以三萜类化合物高达200种以上,是灵芝其和他菇菌无法相比的,具有解毒保肝、抗癌、强化免疫、抗过敏、降血脂等众多功效,被誉为“森林中的红宝石”、“药芝之王”。除了上面提到的几种蔬菜,芦笋、花椰菜、茄子、甜菜、荠菜、苤蓝菜、金针菇、雪里红、大白菜也要记得多吃。水果类:草莓、葡萄、樱桃:富含排毒物质,有利于抑制和消灭血液中加速癌变的物质。水:水是生命之源,人体每天排出的水(汗、尿)和补进的水基本平衡。每天喝足8杯水,能使人体免疫功能健全,没有癌细胞生存、扩散的条件,并能有效地抑制、预防膀胱癌。
(9)木瓜:是木瓜里的维生素C却远远多于橘子的含量,而且木瓜还有助于消化人们体内难以吸收的肉类,能防止胃溃疡。草莓:肉甜汁美的草莓不但汁水充足,对人体健康还有极大好处,尤其爱美的女孩可要多吃点,因为草莓可以让你的肤色变得红润,还能减轻腹泻。有意思的是,草莓还能巩固齿龈、清新口气、滋润咽喉。而且,草莓叶片和根还可用来泡茶,真可谓“浑身是宝”。此外,猕猴桃、芒果、杏、柿子、西瓜这几种香甜多汁的水果也跻身最佳食品之列。
荤菜吃出名堂,荤菜虽然脂肪含量比较大,但却是日常饮食中不可或缺的,所以要吃出点名堂来,荤菜也能给身体均衡营养。进榜的最佳肉食当数鹅肉、鸭肉和鸡肉,张嘉芷教授介绍说,鹅肉和鸭肉的化学结构很接近橄榄油,对心脏有好处,尤其是老人不妨适当多吃点。鸡肉是公认的“蛋白质的最佳来源”,老人、孩子更要及时补充。吃过肉记得喝鲜汤,最优质的汤非鸡汤莫属,特别是母鸡汤,还有防治感冒、支气管炎的作用,尤其是冬春季,也就是现在喝效果更好。养脑巧吃零食,现在用脑过度的人非常多,吃什么最能养脑是这些人最关心的问题,这不,榜上就评出了最佳护脑的食品,还有不少可以当零食吃呢,快来试试吧。
(10)蔬菜中菠菜、韭菜、南瓜、葱、花椰菜、菜椒、豌豆、番茄、胡萝卜、小青菜、蒜苗、芹菜都有补脑作用。此外,核桃、花生、开心果、腰果、松子、杏仁、大豆等壳类零食对脑子也很有好处。粗粮类:玉米、荞麦、莜麦:含有人体所需的维生素、纤维素、微量元素,易被人体吸收,并含有抑癌增殖成分,多食之,可加速肠部蠕动,排除大肠癌因子,降低胆固醇的吸收。薏仁:这是一种常用的中药,含有蛋白质、脂肪、维生素B1、碳水化合物、氨基酸等多种人体所需的营养物质,具有抗肿瘤、利尿、消肿、抗炎、降血糖、增强肌体免疫力的作用,特别是能抑制癌细胞繁殖。
(11)人参皂苷:一种从人参的根茎叶中提取的固醇类化合物,是人参的药理成分。人参中含有四十余种皂苷成分。其中,人参皂苷Rh2、Rg3具有抑制肿瘤细胞分化生产和新生血管的形成,诱导癌细胞凋亡,提高免疫力,抗疲劳,增强抗癌药的药效,对放化疗具有增效减毒的作用,被医学界誉为肿瘤患者的“护命素”。垃圾食品三类食品加重负担世界卫生组织“通缉”的食品前三名是油炸食品、腌制食品和加工类的肉食品。想想看,这三类食品几乎是我们每顿正餐都会出现的,但摄入过多却会加重身体负担。方便食品别图方便饼干、方便面、碳酸饮料都是我们平常图方便时的方便食品,但是方便食品对人的肝脏影响很大,所以被划在垃圾食品行列。方便食品中多有添加剂,上海营养学会赵法汲教授说,方便面含盐量很高,吃多了容易得高血压,而且损害肾脏;饼干里面的食用香精和色素过多,热量太多破坏了维生素,还会对肝脏功能造成负担;膨化食品也不宜多吃,具有高糖、高脂肪、高热量、高味精含量的四高特点,吃多了会破坏营养均衡不说,还容易有饱胀感,影响孩子正常吃饭。
烧烤等同吸食烟毒,现在烧烤越来越火,但是,食物烧烤后是有害健康的。赵法汲教授分析说,由于肉直接在高温下进行烧烤,被分解的脂肪滴在炭火上,再与肉里蛋白质结合,就会产生一种叫苯并芘的致癌物质。这种物质对人体影响最大的是它的强致癌性和突变性。美国一家研究中心的报告说,吃一只烤鸡腿就等同于吸60支烟的毒性,而常吃烧烤的女性,患乳腺癌的危险性要比不爱吃烧烤食品的女性高出2倍。
三类副食不宜常吃:除了上面提到了几种垃圾之外,还有三种副食垃圾不可不防,那就是罐头、果脯和冰淇淋。其实,经过加工的罐头,破坏了水果和鱼肉本身的维生素,会让蛋白质变性,营养成分含量非常低,而且热量还特别多;果脯里有三大致癌物质之一的亚硝酸盐;冰淇淋、雪糕里面的奶油极易引起肥胖,含糖量过高还影响正餐,想减肥的少吃为妙。
(12)生命营养库螺旋藻螺旋藻又名蓝藻,是一种螺旋形的藻类植物.在全球生物资源中,其营养成分和生理活性物质最丰富、最全面,最均衡,被誉为"生命营养库".螺旋藻的用途已由原来单纯动物饲料迅速转为人类的营养食品、医疗和保健食品.目前,全球已有60多个国家认定其为人类营养食品。主要分为以下几种:原料类:①螺旋藻干粉:螺旋藻收获后,经干燥、杀菌等工艺,即可制成食品级或药品级粉剂。如只经脱水自然干燥则为饲料级。②螺旋藻原生液:由螺旋藻干粉加工而成,均为食品级或药品级。③螺旋藻原生粉:由螺旋藻原生液再加工而成,亦为食品级或药品级.目前,国内仅见天藻公司有些类产品报导固体食品类:①螺旋藻小食品:以食品级螺旋藻干粉或原生粉为添加剂、采用科学配方精制面成。目前国内外较为流行的有:螺旋藻营养米粉、螺旋藻营养面包、螺旋藻饼干、螺旋藻软糖、螺旋藻果冻、螺旋藻巧克力、螺旋藻曲奇饼、螺旋藻保健盐以及植物肉松等。②螺旋藻片剂(块剂):方便人们的食用,国内外螺旋藻加工厂都常将螺旋藻粉加工成片剂(丸剂、块剂)。③螺旋藻胶囊:螺旋藻胶囊具有类似紫菜的风味,气味清香,食用方便安全,易被消化吸收。④螺旋藻速溶冲剂:此类产品采用特殊去腥工艺后,不仅味道清新,而且速溶性好,营养成分保存率高。⑤螺旋藻添加剂:如蛋白质营养强化添加剂、天然蓝色色素添加剂等。
(13)饮料类
①原味饮料:如液体饮料、饮料冲剂等。
②氨基酸饮料:如复合氨基酸饮料、比较单纯的氨基酸饮料等。
③果味类混合型饮料:如螺旋藻芒果汁饮料、螺旋藻西瓜汁饮料、螺旋藻葡萄汁饮料,螺旋藻西番莲饮料等。
④多种液汁混合型饮料:主要有螺旋藻天然饮料、螺旋藻彩色珍珠粒饮料螺旋藻与多种蔬液汁混合型饮料、螺旋藻与多种动植物液汁混合型饮料等。
⑤功能性饮料:如螺旋藻茶叶饮料螺旋藻西洋参饮料、螺旋藻枸杞饮料等。
⑥白酒与啤酒:如螺旋藻营养型白酒、开藻螺旋藻啤酒、健康啤酒、超级营养保健啤酒等。
(14)化工、保健、药品类
①化工产品:如藻胆体、藻胆蛋白、叶绿素铜钠盐,玉米黄质(黄色)、蓝溪藻黄素乙(橙红色)、β-胡萝卜素γ-亚麻酸、核酸内切酶等。
②保健品:如钝顶螺旋藻营养酸奶、藻维典、藻维钙泡腾片等。
③美容品:法国、德国等将螺旋藻药片或粉剂,用于减肥美容。中国也已生产出螺旋藻面膜粉、螺旋藻健美块等.
④药品:如荧光分子探针、螺旋藻脂灵、抗糖尿病制剂4高科技防癌新产品-螺旋藻多糖、螺旋藻蓝蛋白等。
(15)饲料类
①配合饲料:以饲料级螺旋藻干粉为添加剂,采用科学配方,制成配混饲料,饲喂虾苗、蟹苗、鳗鲡苗等,或在蛋鸡、肉鸡饮料中添加1-2%螺旋藻干粉均取得显著效果。
②饲料添加剂:如高效营养型饲料添加剂蓝藻精等。
三、抗癌食物排行榜
(1)抗肝癌明星:蘑菇
上榜理由有“抗癌第一菜”的美誉,比如菜蘑、口蘑、香菇等,由于含有多糖体类的抗癌活性物质,可以促进抗体形成,使机体对肿瘤产生免疫能力,抑制肿瘤细胞生长,可以抵抗包括淋巴瘤、肠癌等在内的多种癌症,特别是对肝癌病人,很有益处。
(2)抗肠癌明星:茭白
上榜理由:茭白、芹菜类食物富含纤维,食物进入肠道后,可加快其中食物残渣的排空速度,缩短食物中有毒物质在肠道内滞留的时间,促进胆汁酸的排泄,对预防大肠癌极为有效。此外,经常食用大蒜,也可使患结肠癌的风险降低30%。同时,红薯、卷心菜、麦麸也是极其重要的预防肠癌的食物。
(3)抗胰腺癌明星:菜花
上榜理由:美国《全国癌症学会期刊》近日指出,多吃菜花、西兰花等十字花科食物,能够降低患胰腺癌的风险。研究指出,这可能与食物中含有的天然叶酸有关。同时,由于萝卜中含有芥子油,它和萝卜中的酶能互相作用,具有促进胃肠蠕动、增进食欲、帮助消化的功效。近年来,研究发现,萝卜因此也有助于抵抗胰腺癌。
(4)抗肺癌明星:菠菜
上榜理由:菠菜中含有多种抗氧化物,有助于预防自由基损伤造成的癌症。每天吃1碗菠菜可使患肺癌的几率至少降低一半。此外,番茄、胡萝卜、南瓜、梨和苹果也都可以预防肺癌的发生。
(5)抗乳腺癌明星:海带
上榜理由:海带不但含有丰富的维生素E和食物纤维,还含有微量元素碘。而科学家认为,缺碘是乳腺癌的致病因素之一,因而常吃海带有助于预防乳腺癌。日本女性乳腺癌发病率低,可能与经常摄入海带等海藻类食物有关。同时,红薯、番茄、菱角、荸荠、豆类食品也是能预防乳腺癌的美食。
(6)抗皮肤癌明星:芦笋
上榜理由:芦笋是近年风靡世界餐桌的蔬菜之一,含有丰富的维生素、芦丁、核酸等成分,对淋巴瘤、膀胱癌、皮肤癌有一定疗效。
(7)抗宫颈癌明星:黄豆
上榜理由:用黄豆制成的豆腐、豆浆,可以补充植物雌激素,它所含有的异黄酮、木质素都被认为有抗氧化的作用,能抑制宫颈癌的生长,减少癌细胞的分裂,同时有效阻止肿瘤转移。此外,酸梅、西红柿也是很好的预防宫颈癌的食物。
(8)抗胃癌明星:大蒜
上榜理由:常吃生大蒜的人,胃癌发病率非常低,原因是大蒜能显著降低胃中亚硝酸盐含量,而这是胃癌非常重要的诱因。而经常吃洋葱的人,胃癌发病率比少吃或不吃洋葱的人也要低25%。此外,少吃腌渍食品、熏鱼烤鱼也是预防胃癌的好方法。
四、抗癌明星食物的制备方法
(1)蘑菇抗癌食疗方法:盐水蘑菇将250克蘑菇放在500克水20克盐的盐水中煮熟捞出加麻油2克即可食用,成人每天25克
(2)茭白抗癌食谱:原料:茭白200克,猪肉90克,鸡蛋1枚,植物油100克,酱油、盐、淀粉、葱末、姜末各5克。
做法:
①猪肉洗净切成丝,用鸡蛋、淀粉勾芡搅匀;茭白剥去老皮,截去老根,切成细丝。
②油锅烧热后,加入浆好的猪肉丝炒散,然后放入葱末、姜末、酱油炒拌均匀,下入茭白丝、盐,翻炒至断生入味即可,每次吃250克。
(3)菜花抗癌食用方法;选择菜花时,要挑选品质好的,外观呈乳白色,整体坚固、紧实,中央茂密。由于花菜放在室温下很容易开花,因此花菜如果不急着吃,一定要放入保鲜袋,再放在冰箱冷藏室中。
在烹饪菜花时也要注意,由于花菜的茎部含有丰富营养价值,所以千万别只吃上面的花朵,丢掉根茎。最好是花点时间削掉茎部的老纤维,再和花束一起烹调食用。
主料:花菜200克,鲜虾仁400克
调料:花生油75克,味精8克,盐4克,料酒5克,鸡蛋清30克,豌豆淀粉15克
做法
①花菜去掉根、叶,切成均匀的块,洗净,下沸水锅煮过。锅中放15克花生油烧热,烹入鸡汤30克、味精4克,盐1克,下入花菜烧1-2分钟入味后,淋入8克调制的水淀粉勾好芡,出锅放在盘的四周。
②将鲜虾仁洗净,沥干水,用鸡蛋清、盐1克,淀粉7克浆好,放入热油锅中用温油炸透捞出,沥尽油。
③将锅用火烧热,烹入鸡汤,加入料酒5克、盐2克、味精4克,调好味,然后倒入炸好的虾仁翻炒数下,即可出锅装在盘中央即食,每次吃400克。
菜花在切的时候也有讲究,不能切太碎,容易让上面的小花束掉落,损失营养,最好是用手掰,或者用剪刀剪。另外,由于花菜中的维生素B、维生素C受热易流失,所以烹饪花菜要掌握火候,不能煮太久,西兰花的最佳食用方式是隔水蒸5分钟,抗癌效果最佳。
美国营养学家号召人们在秋季多食用西兰花,因为这时的西兰花花茎中营养含量最高。西兰花对杀死导致胃癌的幽门螺旋菌具有神奇功效。西兰花是含有类黄酮最多的食物之一,类黄酮除了可以防止感染,还是最好的血管清理剂,能够阻止胆固醇氧化,防止血小板凝结,因而减少患心脏病与中风的危险。
有些人皮肤一旦受到小小的碰撞和伤害就会变得青一块紫一块的,这是因为体内缺乏维生素K的缘故。补充的最佳途径就是多吃西兰花。
(4)蒜泥菠菜,大蒜捣成蒜泥,菠菜250克,用开水烫熟沥干加上蒜泥10克、盐3克,麻油2克,调匀即可食用。
(5)蒜泥海带丝:新鲜海带丝200克煮熟,大蒜50克捣成蒜泥和煮熟的海带拌匀,加入麻油2克,盐3克拌匀,每天吃200克。
(6)芦笋500克,去皮煮熟即食。每天吃450克。
(7)黄豆芹菜汁:芹菜100克,鲜黄豆50克,分别煮熟后放到榨汁机及粉碎机里榨汁粉碎即食。
(8)大蒜洋葱汁:生大蒜50克,洋葱50克,温开水100克放在榨汁机里一起搅碎后,全部倒在杯子里加白糖5克即喝,一天一次。
五、食疗验方4则:
(1)西红柿花生大枣粥:大枣和西红柿含有丰富的维生素C,能增强人体的抗癌作用。西红柿中的“蕃茄素”也具有抗癌作用。取花生米、大枣各30-50克,先煮之,熟时再加入洗净的粳米100克煮成粥,食用前拌入洗净切碎的20克西红柿,每日1-2次,每次300克。该粥适用于虚弱的癌症患者,如消化系统(食道、胃、肠、肝、胰、胆)癌症手术后的病人。
(2)海带肉冻:海带内含有海藻多糖,有较强的抗肿瘤功用,其中“磺酰基”可杀灭癌细胞。将海带200克泡软洗净切丝,带皮猪肉50克,洗后切小块,放锅内加150克水,再加桂皮5克、大茴香10克,用文火煨成烂泥状,加盐8克,盛入方盘内,晾冷成冻,吃时切成条佐饭食之。该品适用于内分泌系统的肿瘤(如甲状腺、乳腺、前列腺等)病人食用,每次吃250克。
(3)菱粉粥:用粳米100克加水350克先煮,待煮至米熟后,加入菱粉40克,红番茄50克,同煮为粥。据报道菱角有抗癌作用,适用于食道癌、胃癌、乳腺癌、宫颈癌病人食用,每次吃300克。
(4)蒜苗肉包子:蒜苗内含有微量元素硒,在体内有抑制致癌物的作用:可限制肿瘤发展使其缩小甚至消除。将蒜苗和肉按4:1之比例制成馅,加10克肉包调味品,做成肉包蒸熟食用。适用于一切恶性肿瘤、白血病等,并可预防肿瘤的复发和转移,每次吃350克。
参考资料:
据调查发现,癌症病人的体液PH值100%是酸性的,这样的体液促成了癌细胞的形成与生长。为了改变这种酸性体质,应首先从摄入食物入手,从根源上来控制癌细胞,多吃碱性食物,亦即癌症食疗法。加大纤维素和维生素的摄入,控制肉类的摄入,同时适当通过100微克补硒,有助于体质向弱碱性发展。有关食疗,在世界各国,尤其东亚文化圈内十分推崇。在日本,韩国,中国台湾地区流行的“济阳式食疗法”正是癌症食疗法的代表之一。这种观点和部分详细操作方法,十分适合癌症患者做为饮食调理的指导。
六、禁食抗癌疗法
在欧洲,禁食是作为一种成熟、常规的治疗方法,用于治疗多种疾病。目前,国内禁食疗法的临床运用刚刚起步,开展禁食疗法的相关研究。
1、禁食疗法概述
禁食疗法是指在有限的时间内,除了可以适量饮水、进食少量蔬菜汁、果汁外,禁食其它一切食物,依靠体内的能量储存保障生命活动的需要,来达到治疗或预防某些疾病的一种方法。根据禁食时间长短,可分为间歇禁食和完全禁食。间歇禁食疗法的患者每隔几天完全禁食1d,完全禁食以1周或更长的有限时间为1疗程。完全禁食必须在有条件的医院、有经验的医护人员监护下进行。
2、禁食疗法的现状
在欧美许多国家以及新加坡、泰国等,禁食疗法正在成为一种时尚,被认为是一种“绿色”的自然疗法。国外已经有许多禁食医院和禁食团体开展禁食治疗。如德国北莱茵-威斯法伦州埃森市中心医院就设有禁食疗法住院部,澳洲有悉尼健康中心,英国有克拉斯综合病院,以禁食治病而驰名世界[1]。
3、禁食疗法的适应证
根据治疗效果的不同,可将适应症分为3个层次。一类适应证为:脂肪肝、血脂异常、肥胖症、超重、高血压、骨性关节炎、风湿性关节炎、睡眠呼吸暂停综合征、便秘;二类适应证为:2型糖尿病、代谢综合征、胃肠功能紊乱、肠易激综合征、狂食症、韧带肌肉病、痤疮、更年期综合征、吸烟、酗酒;三类适应证为:过敏、哮喘、后背痛、支气管炎、念珠菌病、感冒或流感、憩室炎、憩室病、枯草热、头痛。
4、禁食疗法的禁忌证
禁食疗法同其他任何疗法一样都具有一定的局限性和禁忌证,下列患者是不适合进行禁食治疗的:年龄在18岁以下和70岁以上;完全失明、失聪;失去意识或恐怖性精神病及痴呆;阿兹海默氏症;神经性厌食症;酒精中毒性精神病;癫痫、精神分裂症;麻痹性疾病;脑中风引起的麻痹;严重的慢性感染;广泛肿瘤和转移肿瘤;艾滋病;胃溃疡出血;妊娠、哺乳;身体虚弱、过度消瘦、营养不良者;1型糖尿病;2型糖尿病口服药物控制不佳,需连续注射胰岛素;心脏衰竭或心律不齐;肝硬化或肝炎等肝病患者(除外脂肪肝);尿毒症;继发性高血压。
5、禁食期间的不良反应
根据国外禁食研究,禁食中有的患者可能会出现头晕、头疼、乏力、口腔异味、舌苔增厚、饥饿感、胃胀、胃痛、失眠、焦虑、恶心、呕吐等不适,实验室检查中可出现一过性尿酸升高、尿中酮体增加、血脂反应性变化等。这些不良反应一般症状较轻,可耐受,在禁食结束后可迅速恢复正常。恢复饮食3周后血脂会发生良性转变,即低密度脂蛋白胆固醇降低,高密度脂蛋白胆固醇升高。
6、禁食疗法研究进展
禁食疗法即时作用为体重降低,一般经过1周的禁食后,男性体重可下降4-5kg,女性可下降3-4kg。禁食结束后,其远期效应逐渐显现出来,患者对体重、健康更加关注,生活方式、饮食习惯发生明显变化。
7、禁食疗法的安全性研究
黄光华等观察实验对象在21d禁食期间,每日坚持正常的散步、登山等各项活动。在能量消耗大大超过摄入热量的情况下能保持正常人的体力和脑力,所观察的各项生理指标均较稳定,各种生化指标和消化吸收功能测定未发现对人体机能有损害。
Michalsen等[3]在一个大型的前瞻性队列研究中,选择13年中连续性住院病人2121例,住院期间952人给予了禁食,873人给予正常热量的蔬菜饮食,296人给予其他饮食,出院后3个月、6个月进行随访,发现出院后禁食病人较非禁食病人主要疾病得到明显改善(P<0.01)。禁食期间有23名患者终止禁食,2名患者禁食期间血钠一过性降低,1名患者禁食中血尿酸水平达11.2mg/dL,给予别嘌醇治疗后尿酸恢复正常。4名患者禁食中有轻度胃痛。禁食期间没有严重的不良反应的报道。
8、禁食对体重的影响
Ziaee V[4]观察在斋月期间,超重患者禁食后体重下降,Lefevre M等[5]研究发现即使在健康非肥胖者,禁食可以减轻体重,降低血脂和血压等心血管疾病的风险。
9、禁食对血压的影响
禁食除了可以降低体重外还可以降压,禁食降压的机理可能跟禁食后经肠道吸收入血量减少,循环血容量降低,心输出量减少有关。Brinkworth GD[6]认为在超重和肥胖患者,给予热量限制后引起的降压作用不会反弹。
10、禁食对神经内分泌的影响
Michalsen等人[7]选择慢性疼痛综合征病人进行禁食后发现:禁食组和对照组体重分别下降(4.8±1.2)kg和(1.6±0.9)kg,禁食组的瘦素水平明显降低,皮质醇水平增加17%,禁食后期情绪评分显著增加,但是这种增加和体重减轻无关。禁食导致相对情绪提升,与瘦素、皮质醇的变化无关,说明禁食使慢性疼痛综合征患者短期情绪提高,但与体重减轻导致瘦素缺失无关。
Michalsen等人[8]共选择28例住院病人,其中22例作为禁食组和6例作为素食对照组,经过1周的改良性禁食,测定夜间尿皮质醇、儿茶酚胺,结果发现禁食组尿去甲肾上腺素、肾上腺素、皮质醇明显增加,而对照组激素水平没有明显改变;年龄小于50岁,BMI>25kg/m2的患者,神经内分泌反应显著;皮质醇水平比基线低的患者,禁食更能显著增加皮质醇的排泄;禁食没有明显增加两组的情绪。此研究说明禁食的耐受性良好,大多数患者从禁食中获益颇多,短期禁食对神经内分泌系统有促进作用,反应程度依赖个体代谢和激素的基线水平。
11、禁食血脂代谢的影响
Roky R等[9]观察间断性禁食对人体生理和生物节律的影响,发现间断性禁食没有明显影响禁食者血脂、糖类、蛋白质代谢和每天平均激素水平,其升高高密度脂蛋白胆固醇(HDL-C)、载脂蛋白A1,降低低密度脂蛋白胆固醇(LDL-C)。Dikensoy E等[10]观察禁食禁忌证孕妇血脂、可的松水平和胎儿生长的影响后发现,禁食期间孕妇血可的松水平升高,LDL-C/HDL-C降低,禁食对胎儿生长没有产生不利影响。Aksungar FB[11]研究发现禁食期间血清总胆固醇,甘油三酯和LDL-C的水平无显著变化,禁食期间和之后男女TC/HDL-C比降低,空腹组则没有变化;禁食组白细胞介素-6、CRP、同型半胱氨酸水平明显低。Larson-MeyerDE[12]认为禁食有利于减少超重患者肝脏脂质和降低甘油三酯。Lamine F[13]认为禁食可以增加HDL-C。Maislos[14]发现禁食后血浆高密度脂蛋白增加23%,饮食的改变并没有影响低密度脂蛋白,极低密度脂蛋白或脂蛋白(a)。
12、禁食对血液循环的影响
戴闽星等[15]报道,观察62例禁食者体外模拟血栓指标,发现禁食明显地抑制体外模拟血栓的形成,表明禁食具有明显降低血液凝聚性和改善血液流动性,起到促进血液循环、改善和增强全身组织血氧供应的作用。
13、禁食对糖代谢的影响
Halberg N[16]观察健康成年男性禁食和恢复饮食胰岛素活动,结果表明间歇禁食可以增加人类胰岛素介导的葡萄糖摄取率,结果符合节俭基因的概念。Bouhlel E[17]发现禁食明显降低体重和血脂,但没有扰乱血糖调节或GH/IGF-1系统活动。Hachemi S[18]观察为期1个月的斋月禁食对糖尿病人的影响,发现2型糖尿病人可耐受,对合并肥胖的患者尤为适合。M'guil M[19]认为斋月禁食可使糖尿病得到很好的控制,各项生化指标保持在生理范围。
禁食疗法具有良好的应用前景,国外已经有大量的基础及临床研究证实禁食疗法的安全性和有效性。国内治疗性禁食的研究起步较晚,大多处于实验研究阶段,尚未有将治疗性禁食用于临床治疗的报道。有必要开展国人禁食相关安全性、有效性的临床研究,通过国人禁食研究积累临床资料,为此项疗法在临床上的成功开展奠定基础。
14、清理肠胃、排除大肠毒素。
(1)禁食清肠前几天饮食要清淡
有些禁食清肠食谱就是在开始禁食清肠前一天或几天开始吃清淡饮食。多吃水果、蔬菜和清淡的食物如肉汤。这有助于身体适应新食谱。
(2)做清肠用饮料
无论是吃生食还是液体禁食,你都需要大量健康的液体。保证禁食清肠过程中每天至少喝三次水,每次至少220毫升。以下是一些饮料方案:
①开始时,将1/4杯温水、1/4杯柑橘汁和一汤匙泻盐混合。在禁食的第一天喝两次。
②将1/2杯有机苹果汁和1/3杯水混合,膨润土、乳清粉和亚麻籽各加入一汤匙。搅拌均匀,立即饮用。
③用羽衣甘蓝、菠萝、胡萝卜和梨榨汁,制作绿色果汁。
(3)补充水分
除去特殊的饮料,保证每90分钟喝一些水。你也可以喝新鲜果汁、草药茶和清汤。为饮料腾出肚子。
(4)清理肠道时加一些放松和轻运动
桑拿、按摩、深呼吸和散步有助于释放体内毒素。不过一定不要过度,因为禁食过程中你的能量会稍微低一点。
(5)3-6天后停止禁食
禁食时间过长会对健康产生不良影响。开始吃饭时先吃少量蔬菜和水果——不要对消化系统施加过多压力。第一天生吃或吃清蒸的蔬菜。规律饮食可以在停止禁食的第二天恢复。
(6)禁食结束后生活方式要健康
吃含有益生菌的食品如酸奶、大酱。规律锻炼,多喝水。吃包含膳食纤维的均衡饮食。
如果你开始感到头晕、乏力、疲劳,禁食可能弊大于利。如果这些不好的症状持续出现,立即停止禁食。如果再正常进食不能帮助你恢复身体健康,一定要去看医生。
禁食清肠一定要谨慎,特别是糖尿病、心脏病人不适宜禁食,孕妇和老人也不适宜禁食,如果在禁食过程中或禁食后出现头晕、脱水等现象一定要立即停止禁食清肠。
七、心理抗癌疗法
抗癌,选择方式跟早治疗一样重要!癌症患者亟待心理治疗对于癌症患者而言,肉体的折磨与内心的煎熬一样令人痛不欲生。一项调查表明,我国癌症患者中约有66%患抑郁症,10%患精神衰弱症,8%患强迫症,40%~50%的癌症患者都有焦虑症和抑郁症,很多患者因心理负担过重而导致死亡。而通常的癌症治疗方法在注重治疗患者肉体病痛的之时,往往忽视了治疗他们的心理问题,帮助他们走出心理阴霾,以积极健康的心态抵抗癌症。
大量临床观察发现,凡精神乐观、战胜癌症信心强、家庭及社会给予温暖多的患者生存时间长,而且生存质量高。而那些丧失求生意志的人,生存时间短而且质量差。因此,帮助癌症患者建立良好的心理环境,保持良好的精神状态,可以提高人体的免疫功能和抗病能力,使体内各组织细胞的功能正常,各器官间重新趋于协调。在接受癌症治疗的时候,将获得事半功倍的效果。
肿瘤医院生物诊疗中心的专家介绍,现代抗癌心理疗法常采用心理干预的方式治疗癌症的心理抵抗力,改善患者的主观态度,提高治疗信心。
心理治疗常采用以下方法:
(1)心理支持疗法:通过家属、朋友、医生的真诚、热情的帮助,解除思想上的负担,给患者以心理上的支持,树立患者积极的生活信心;
(2)放松疗法:患者或坐、或卧,保持自然舒适的体位倾听音乐,想象自己在练习瑜伽,想象全身的癌细胞被杀死;
(3)催眠暗示疗法:应用催眠术使病人处于恍惚状态,转移患者注意力,减轻疼痛感。生物反馈疗法等多种疗法综合运用,各种疗法可以有叠加的效果。此外还可以通过使用抗焦虚药、抗抑郁药、抗精神病药物治疗手段,减轻癌症带来的的焦虚、抑郁、精神分裂症等症状。
治愈癌症的实例表明,乐观的精神与健康的心理是最好的良药。任何医疗技术与药物都无法代替精神与心理健康在治癌过程中的巨大作用。作为生物抗癌技术代表之一的CLS生物治疗法强调以生物抗癌技术为主导的同时,根据癌症患者的认知过程,影响其情绪和行为,改变癌症患者的误区,达到全面治疗患者的身心健康的目的,目前,重庆地区首家生物治疗中心在重庆肿瘤医院落户。
(4)信心疗法
有一个真实的故事:几个人和一名年轻人开玩笑,他们把这个年轻人的双手和双脚捆起来,蒙住双眼,并把他抬到一条已经不用的铁轨上,邻近的铁轨上正好有一列火车呼啸而过。当那几个人上前为他松绑时,发现这个年轻人已经死亡。
美国心理学教授指出,他的死因不仅是由于恐惧,而且是死于信念。当人和动物认定自己生还无望时,这种认定自己必死无疑的信念有时也会造成死亡的悲剧。
科学研究证明,每个人都有一种超乎寻常的潜能。它一旦被激发出来后,它将使人得到意外的收获,甚至会出现奇迹。信心就可以激发这种潜能。所以患病后要尽快摆脱不良的情绪,下决心不管忍受多大的痛苦,顽强地战胜疾病。相信奇迹会在自己身上发生。
(5)想象疗法
在放疗时,可以想象射线在杀死自已身体里的癌细胞。没事时,病人就想象自己的全身通畅。有一点像瑜珈功。在进行想象疗法时,身体要放松,杂念应抛弃。
(6)安慰疗法
家属、朋友、医生帮助病人解除思想上的负担,消除顾虑。
(7)音乐疗法
听音乐,但是听的时间不宜过长,音量以70分贝以下最佳。
(8)幽默疗法
医学家们发现,癌症病人有规律地笑,可使病情得到缓解。
八、植物抗生素疗法
(1)将新鲜大蒜剥除外皮,剔除杂质,捣成蒜泥;
(2)取蒜泥1000克,加入95%食用乙醇1000克,放入容器内混合后密封贮存10-15天;
(3)过滤除渣得乙蒜液1300克,加入3克维生素B1,得乙蒜混合液;
(4)将乙蒜混合液二次密封存贮3-5天即得植物抗生素,每日口服3克,每次15克。
本发明的工艺是基于以下思路设计的将大蒜素口服制剂含量控制在0.01%~0.05%之间对于人体是适中和安全的,并且大蒜素N只有在乙醇的化学作用下,才具有抗血栓形成的功能。所以本发明工艺分成两步密封的目的就是为了以最短时间无污染,无添加剂取得合适浓度,大蒜素与乙醇反应充分的合成物。第一次密封浸泡后,大蒜素的含量可以控制在0.01~0.05%浓度之间,将渣弃去后,溶液静置后分上下两层,上层为清液,测得酒精度在80°左右,而下层溶液粘稠,因此第一次密封主要是一种萃取的物理过程,所提取的大蒜素与乙醇反应还不充分。第二次密封后,由于合成物各种成分接触面积增大,使大蒜素与乙醇反应更完全、成熟。实测二次密封后溶液的酒精度为42°,且毫无酒味。所以二次密封主要是化学反应的过程。这些反应过程包括蒜氨酸经大蒜酶水解产生大蒜素,以及化合产生烯丙基,丙基或甲基组成的硫醚化合物。尤其是在这一过程加入B1维生素,对许多反应起到催化作用,如促使大蒜素经与硫胺素反应生产帮助人体分解葡萄糖的蒜胺物质,帮助提取具有抑制血小板聚集活性作用的阿霍烯等等。
本发明同现有大蒜素提取方法比较,具有以下积极效果。其一工艺简单,成本低,本发明只需在常温、常压条件下将大蒜置阴凉处即可。其二由于本方法所得产品非大蒜素纯品,因此性质稳定,存放时间长,而且生产工艺条件均在自然条件下,溶剂为食用酒精,所以反应物质及产物无害且浓度适中,食用安全。其三本工艺的产物丰富,几乎所有产物对人体均有益处,因而比起现有工艺所得的大蒜素更具营养价值。
以下通过实施例对本发明做进一步描述。
按下列工艺提取A、B、C三组大蒜素。
新鲜大蒜去皮,洗净→破碎→捣成蒜泥+等重的95°食用酒精→第一次密封10-15天→过滤→第二次密封 3-5天→过滤→成品。
密封处理即将蒜泥和食用酒精混合物装满容器,容器口塞牢,并与外界空气泥封隔开,置通风阴凉暗处。
1、对病原微生物的影响
植物抗生素具有较强的抗菌消炎作用,对多种球菌、杆菌、真菌、病毒等均有抑制或杀灭作用。植物抗生素对多种致病菌如葡萄球菌、脑膜炎、肺炎双球菌、链球菌及白喉、痢疾、大肠杆菌、伤寒、副伤寒、百日咳、结核杆菌和霍乱弧菌等都有明显的抑制或杀灭作用。可治疗急性菌痢、百日咳、婴儿腹泻、大叶性肺炎、肺结核、伤口化脓、沙眼等。植物抗生素抗菌的原理是由于植物抗生素分子中的氧原子与细菌生长繁殖所必需的半胱氨酸分子中的巯基相结合而抑制了细菌的生长和繁殖。
植物抗生素对多种致病真菌包括白色念珠菌有抑制或杀灭作用。低浓度时主要抑制真菌生长,高浓度时可完全杀死真菌。临床已用于治疗隐球菌脑膜炎、肺部及消化道真菌感染、白色念珠菌毒血症、白色念珠菌引起的小儿消化不良、真菌性角膜炎、新生儿鹅口疮、头癣等[。植物抗生素的抗真菌机制是:通过对巯基的氧化使蛋白质灭活;对含巯基的化合物如胱氨酸、谷胱氨酸发生竞争性抑制;非竞争性地抑制真菌内某些酶的活性。
巨细胞病毒(CMV)感染是导致骨髓移植失败和患者死亡的主要原因之一,至今缺乏有效的防止措施。临床研究发现植物抗生素对骨髓移植者并发人巨细胞病毒感染有明显的防治作用。隐孢子虫(Crypt 0sp 0ridium)是一种新发现的病原体,可引起婴幼儿腹泻,对隐孢子虫所致腹泻,目前尚无特效药,国内试用植物抗生素治疗取得了较好疗效。植物抗生素能有效杀伤弓形虫速殖子,可抗弓形虫感染、特别是抗弓形虫病复发的作用较明显。植物抗生素的二丙烯基二硫醇溶液对乙肝病毒表面抗原的破坏率达43.5%,证明植物抗生素对乙肝病毒表面抗原有一定的破坏作用。植物抗生素还具有抗原虫滴虫作用,经临床验证对阿米巴痢疾、滴虫性阴道炎有很好的治疗作用。
2、对消化道系统的影响
慢性胃病:植物抗生素具有降低胃内亚硝酸盐含量和抑制硝酸盐还原菌的作用。用植物抗生素治疗萎缩性胃炎患者,服药1个月后胃液pH值降低,酸度增加,且降低胃液内亚硝酸盐含量。植物抗生素用于治疗慢性胃病,对胃区不适、饱胀、隐痛、返酸、嗳气、烧灼及食欲不振等症状者有明显改善,提示植物抗生素对慢性胃病有一定治疗作用。
幽门螺杆菌(HP)相关性消化性溃疡:研究证明,幽门螺杆菌感染是消化性溃疡的主要原因。植物抗生素对消化道细菌的抗菌杀菌作用明显。临床应用植物抗生素对HP相关性消化性溃疡进行治疗,结果证实植物抗生素对治疗HP相关性胃、十二指肠溃疡有效。
慢性结肠炎:慢性结肠炎所致慢性腹泻是消化系统疾病常见的一种临床表现。王德立等应用米雅BM制剂(主要含酪酸菌)和植物抗生素联合治疗慢性结肠炎患者52例,结果显示植物抗生素对治疗慢性结肠炎所致腹泻有良好的疗效。
保护肝脏作用:植物抗生素对四氯化碳诱发大鼠肝损伤引起的血清岍和脂质过氧化物丙二醛水平的升高有明显的抑制作用,这种作用具有剂量效应关系。认为植物抗生素对化学性肝损伤的保护作用机理是植物抗生素可抑制脂质过氧化物对膜结构的损伤。植物抗生素可剂量依赖性地阻抑小鼠肝组织内GSH耗竭及GST下降,增加肝细胞中谷胱甘肽s一转移酶的活性,增加肝脏的结合解毒功能,从而对肝脏乃至整个机体起保护作用植物抗生素可通过提高肝脏环腺苷酸的水平,调节脂质代谢膜转运及细胞增殖,并增加酶的活性,使血脂水解增加,生物合成降低,增加血脂成分的排泄,维持血清、肝、肾的脂蛋自及甘油三酯在正常范围内,从而防治脂肪肝。
3、对心脑血管及血液系统的影响
植物抗生素对心血管的作用是通过降低血浆总胆固醇、降血压、抑制血小板活性、降低红细胞压积、降低血液粘度等作用来实现的。李格等将植物抗生素用于心肌缺血再灌注损伤的防治。毛建兰等发现脑梗塞急性期外周血白细胞滤过指数明显升高,经植物抗生素治疗后,在症状改善的同时白细胞滤过指数明显降低,全血流变学指标也有改善。研究表明植物抗生素具有活血化瘀、散寒通络之功效,应用植物抗生素治疗冠心病心绞痛、周围血管病取得了良好的疗效。利用植物抗生素片可以降低机体血浆内皮素(ET)的水平,这对预防和缓解冠脉痉挛、减小外周血管张力有重要意义。植物抗生素片对血浆一氧化氮(N0)浓度有升高作用,这有利于防止冠脉痉挛,而使机体保持冠脉舒张状态。同时植物抗生素对体内胆固醇值和纤维蛋白原量的增加具有抑制作用,可提高纤维蛋白溶解活性,表明植物抗生素片能有效地减轻或消除冠心病心绞痛患者动脉粥样硬化的发生和血栓的形成。贾海忠等观察植物抗生素对不稳定型心绞痛高血压的影响,发现植物抗生素对收缩压和舒张压均有明显降低作用,且降压速度比葛根素快。植物抗生素降压的机制可能是通过钙拮抗,扩张外周血管起作用,也可能通过协同降压作用。
植物抗生素抗心律失常的作用亦引起一些学者的关注。Martin等报道植物抗生素有减慢窦性心率、抑制心肌收缩、抗心律失常的作用。国内有关专家指出,植物抗生素通过延长心肌细胞的有效不应期、降低自律性,起到抗心律失常的作用,因而可用于以快速心率为基础的心律失常,如早搏、心动过速等,可作为辅助疗法。
4、对肿瘤的影响
有实验证实植物抗生素具有预防胃癌发生的作用,其对胃液分离出的硝酸盐还原菌的生长,及其产生亚硝酸盐的能力均有明显的抑制作用,可降低人体胃液中亚硝酸盐含量,从而降低患胃癌的风险。用植物抗生素治疗患者的免疫指标也表明,在接受治疗后,多数患者巨噬细胞的吞噬率及淋巴细胞转化率都明显升高。CAMP是肿瘤细胞生长的阴性信号,任何途径提高细胞内CAMP水平均可抑制肿瘤组织的生长,促使其分化。植物抗生素可提高肿瘤组织内CAMP水平,可抑制肿瘤组织的过度生长增殖”。解云涛等在植物抗生素抑制小鼠S180生长的研究中,从透射电镜中观察到肿瘤细胞膜和核膜皱缩断裂,线粒体出现肿胀和空袍样改变,表明植物抗生素对肿瘤细胞有直接杀伤作用。张桂梅等研究了植物抗生素对巨噬细胞杀灭和抑制小鼠S180肉瘤细胞、艾氏腹水癌细胞及肝癌细胞活性的影响,研究表明,植物抗生素单独或与其它激活剂协同作用时,具有增强巨噬细胞的抗肿瘤活性作用,同时可增强某些瘤细胞对巨噬细胞介导的细胞毒作用的敏感性。孙丽研究结果显示:植物抗生素能诱导肿瘤细胞凋亡,其原因可能和端粒酶活性下降有关。端粒酶活性下降后,端粒缩短,细胞有丝分裂受阻,导致细胞凋亡。有人用流式细胞法(FCM)分析癌细胞周期时,发现植物抗生素可以阻滞肿瘤细胞从G1期进入S期,使G1期细胞堆积,进而抑制细胞的增殖。有实验证明人肿瘤组织中存在表皮生长因子(EGF),EGF存在于癌细胞的细胞质中,在癌细胞核及无癌部分均未发现EGF,并提示癌组织中的EGF是由人肝癌细胞产生的。Moyer等证明植物抗生素能显著抑制人肝癌细胞表皮生长因子受体(EGFR)的表达,明显降低EGF刺激人肝癌细胞造成的EGFR的上调,从而实现抑制癌细胞生长的作用植物抗生素还能抑制皮肤癌,结肠癌,食道癌,鼻咽癌,肝癌的增长。原因之一是因为植物抗生素能防止自由基的形成从而减小了损害DNA、细胞膜和细胞蛋白的机会。
5、对糖代谢的影响
糖尿病是以血糖增高和尿糖为特点,进而导致多脏器损的综合征。如何逆转糖尿病的高血糖状态一直是国内外学者研究的焦点。胰岛素在调节机体血糖水平时起着非常重要的作用。动物实验表明,不同剂量的植物抗生素均可降低血糖值,其降血糖的作用主要是通过升高血清胰岛素水平来实现的。同时病理学证实植物抗生素,主要是通过促进胰腺泡心细胞转化、胰岛细胞增殖,使胰岛素分泌增加,而发挥降血糖作用。而且植物抗生素在体内同脂肪、糖、蛋白质结合后生成脂质蒜素、糖质蒜素、复合蛋白质,这些结合物发挥作用得到一种与维生素E相同的效果。维生素E除具有抗氧化作用外,还具有改善胰岛素的效应,关键是维持胰岛内分泌细胞内质网结构的完整性,保证胰岛素的合成与分泌。
6、对生殖系统的影响
实验证明,植物抗生素对大鼠、田鼠及人的精子具有抑灭作用。抑精作用的强弱与药物浓度相关。被杀死的精子未发现有形态学上的变化,雄大鼠吸入此药并不干扰正常精子的发生,且效果比棉酚好。同时,它在有效抑精浓度对阴道局部没有刺激作用,也不抑制乳酸杆菌的生长、繁殖,既不会导致局部的不良反应,也不会干扰阴道正常菌群。另据报道植物抗生素能增强豚鼠离体子宫的收缩频度和幅度,作用与垂体后叶素相似。
7、对机体免疫机能的影响
植物抗生素是一种较好的免疫激发性中草药。有人在植物抗生素对小鼠免疫功能影响的实验中发现,服药组的脾脏、胸腺_的重量均有增加,T淋巴细胞激活增加,脾脏抗体形成细胞数量增加,单核细胞分泌水平提高,溶菌酶释放增加,因此植物抗生素可提高细胞免疫、体液免疫和非特异性免疫功能。
8、对其他方面的影响
植物抗生素对铅中毒小鼠的致死效应具有拮抗作用,能提高铅中毒小鼠的存活率。对于慢性铅中毒小鼠能降低其组织中的铅含量,且植物抗生素的排铅作用是持续的,能有效地排出机体内蓄积的铅。此外,植物抗生素还具有除头皮屑、抗搔痒、防止神经痛、治疗汞中毒、抗辐射、抗氧化、保护生物膜、抗衰老、防治蚊虫叮咬、抗感冒等医疗保健作用。
具体实施方式
以下通过试验例来进一步阐述本发明所述药物及食疗的有益效果,这些试验例包括本发明药物的动物试验报告及临床疗效观察资料。
[试验例1]本发明药物的动物毒性的试验报告
取新西兰家兔30只,雌雄兼用,体重2.0-2.5kg,分两组,每组15只,其中一组为正常量试验组,另一组为超剂量试验组,将抗癌胶囊用蒸馏水稀释配制成混悬液,采用灌胃法给药,正常量组为0.3g/kg,超剂量组为0.5g/kg,每天2次,连服7天,每天观察用药后二组家兔的反应情况,结果显示二组家兔饮食活动正常,本发明药物无毒副作用。
[试验例2]本发明药物的临床观察资料
1、一般资料
收治门诊肺癌患者26人,其中35岁以上18例,55岁以上8例。
2、治疗方法
①取抗癌胶囊给患者服用,每日口服3次,每次15克,饭后白开水送下,连服3个疗程,每个疗程2个月;
②蒜泥菠菜、菜花或对症食疗及验方选择一种,交替服用,每日3次。
3、疗效评定标准
显效:经过3个疗程治疗后,原发于支气管黏膜或肺部的癌肿消失,咯血、发热、咳嗽、胸痛的症状消失,患者身体恢复正常,观察一年后无复发;
好转:胸痛、咳嗽、发热、咯血症状得到有效控制,逐步恢复正常;
无效:达不到好转标准者。
5、治疗结果(见下表):
经过3个疗程的治疗后,26例肺癌患者中,显效18例,好转7例,无效1例,显效率为69.23%,好转率为26.92%,总有效率为96.15%。
Claims (8)
1.一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法,其特征在于:所述药物组分的用量在下述重量范围内都具有较好的疗效:
西洋参 40-60克 高丽参 40-60克 党 参 40-60克
丹 参 40-60克 赤 芍 40-60克 当 归 40-60克
川 芎 40-60克 黄 芪 80-120克 百 合 80-120克
山兹姑 80-120克 芦 笋 150-250克。
2.根据权利要求1所述的治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法,其特征在于:各原料药的用量为:
西洋参 50克 高丽参 50克 党 参 50克
丹 参 50克 赤 芍 50克 当 归 50克
川 芎 50克 黄 芪 100克 百 合 100克
山兹姑 100克 芦 笋 200克。
3.根据权利要求1或2所述药物的制备方法,它包括下列步骤:
(一)备料
(1)西洋参:原药用清水喷潮,覆盖湿布,夏秋润2天,冬春润3天,取出切片,晾干;
(2)高丽参:取原药材,润透,切薄片,干燥;
(3)党参:洗净泥沙后润透去芦,切片或切段,晒干;
(4)丹参:拣净杂质,除去根茎,洗净,捞出,润透后切片,晾干;
(5)赤芍:取原药材,除去杂质,大小分档,洗净,润透,切薄片,干燥,筛去碎屑;
(6)当归:拣去杂质,洗净,闷润,稍晾,切片晒干;
(7)川芎:拣去杂质,分开大、小个,用水浸泡,晒晾,闷润后切片,干燥;
(8)黄芪:拣净杂质,除去残留的根头和空心较大的根,用水浸泡,捞出,润透后及时切片,晒干;
(9)百合:拣去杂质,黑瓣,簸除灰屑;
(10)山兹姑:除去须根,洗净,清水浸泡2-4小时,取出润透,切片,晒干;
(11)芦笋:春、夏采挖,晒干;
(二)制备
(1)将炮制好的西洋参、高丽参、党参、丹参、赤芍、当归、川芎、黄芪、百合、山兹姑、芦笋放入煎药容器内加水煎煮二次,第一次加水8 倍量,煎煮1.5 小时,第二次加水6 倍量煎煮1 小时,合并两次煎煮液,过滤得滤液;
(2)将滤液浓缩成比重为1.35 的浸膏,加90%-95% 乙醇进行醇沉,回收乙醇并浓缩,在45-50℃下干燥,制得干浸膏;
(3)将干浸膏粉碎成粉,装入胶囊。
4.根据权利要求1所述的治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法,其特征在于:所述的食疗制备方法还包括抗癌明星食物的制备方法:
(1)蘑菇抗癌食疗方法:将250克蘑菇放在500克水20克盐的盐水中煮熟,捞出加麻油2克即可食用,成人每天25克。
(2)茭白抗癌食谱:原料:茭白200克,猪肉90克,鸡蛋1枚,植物油100克,酱油、盐、淀粉、葱末、姜末各5克;
做法:
①猪肉洗净切成丝,用鸡蛋、淀粉勾芡搅匀;茭白剥去老皮,截去老根,切成细丝;
②油锅烧热后,加入浆好的猪肉丝炒散,然后放入葱末、姜末、酱油炒拌均匀,下入茭白丝、盐,翻炒至断生入味即可,每次吃250克;
(3)菜花抗癌食用方法;选择菜花时,要挑选品质好的,外观呈乳白色,整体坚固、紧实,中央茂密,由于花菜放在室温下很容易开花,因此花菜如果不急着吃,一定要放入保鲜袋,再放在冰箱冷藏室中;
在烹饪菜花时也要注意,由于花菜的茎部含有丰富营养价值,所以千万别只吃上面的花朵,丢掉根茎,最好是花点时间削掉茎部的老纤维,再和花束一起烹调食用;
主料:花菜200克,鲜虾仁400克;
调料:花生油75克,味精8克,盐4克,料酒5克,鸡蛋清30克,豌豆淀粉15克;
做法
①花菜去掉根、叶,切成均匀的块,洗净,下沸水锅煮过,锅中放15克花生油烧热,烹入鸡汤30克、味精4克,盐1克,下入花菜烧1-2分钟入味后,淋入8克调制的水淀粉勾好芡,出锅放在盘的四周;
②将鲜虾仁洗净,沥干水,用鸡蛋清、盐1克,淀粉7克浆好,放入热油锅中用温油炸透捞出,沥尽油;
③将锅用火烧热,烹入鸡汤,加入料酒5克、盐2克、味精4克,调好味,然后倒入炸好的虾仁翻炒数下,即可出锅装在盘中央即食,每次吃400克;
菜花在切的时候也有讲究,不能切太碎,容易让上面的小花束掉落,损失营养,最好是用手掰,或者用剪刀剪,另外,由于花菜中的维生素B、维生素C受热易流失,所以烹饪花菜要掌握火候,不能煮太久,西兰花的最佳食用方式是隔水蒸5分钟,抗癌效果最佳;
秋季多食用西兰花,因为这时的西兰花花茎中营养含量最高,西兰花对杀死导致胃癌的幽门螺旋菌具有神奇功效,西兰花是含有类黄酮最多的食物之一,类黄酮除了可以防止感染,还是最好的血管清理剂,能够阻止胆固醇氧化,防止血小板凝结,因而减少患心脏病与中风的危险;
有些人皮肤一旦受到小小的碰撞和伤害就会变得青一块紫一块的,这是因为体内缺乏维生素K的缘故,补充的最佳途径就是多吃西兰花;
(4)蒜泥菠菜,大蒜捣成蒜泥,菠菜250克,用开水烫熟沥干加上蒜泥10克、盐3克,麻油2克,调匀即可食用;
(5)蒜泥海带丝:新鲜海带丝200克煮熟,大蒜50克捣成蒜泥和煮熟的海带拌匀,加入麻油2克,盐3克拌匀,每天吃200克;
(6)芦笋500克,去皮煮熟即食,每天吃450克;
(7)黄豆芹菜汁:芹菜100克,鲜黄豆50克,分别煮熟后放到榨汁机及粉碎机里榨汁粉碎即食;
(8)大蒜洋葱汁:生大蒜50克,洋葱50克,温开水100克放在榨汁机里一起搅碎后,全部倒在杯子里加白糖5克即喝,一天一次。
5.根据权利要求1所述的治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法,其特征在于:所述的食疗制备方法还包括食疗验方4则:
(1)西红柿花生大枣粥:大枣和西红柿含有丰富的维生素C,能增强人体的抗癌作用,西红柿中的“蕃茄素”也具有抗癌作用,取花生米、大枣各30-50克,先煮之,熟时再加入洗净的粳米100克煮成粥,食用前拌入洗净切碎的20克西红柿,每日1-2次,每次300克,该粥适用于虚弱的癌症患者,如消化系统食道、胃、肠、肝、胰、胆癌症手术后的病人;
(2)海带肉冻:海带内含有海藻多糖,有较强的抗肿瘤功用,其中“磺酰基”可杀灭癌细胞,将海带200克泡软洗净切丝,带皮猪肉50克,洗后切小块,放锅内加150克水,再加桂皮5克、大茴香10克,用文火煨成烂泥状,加盐8克,盛入方盘内,晾冷成冻,吃时切成条佐饭食之,该品适用于内分泌系统的肿瘤:甲状腺、乳腺、前列腺癌症的病人食用,每次吃250克;
(3)菱粉粥:用粳米100克加水300克先煮,待煮至米熟后,加入菱粉40克,红番茄50克,同煮为粥,据报道菱角有抗癌作用,适用于食道癌、胃癌、乳腺癌、宫颈癌病人食用,每次吃300克;
(4)蒜苗肉包子:蒜苗内含有微量元素硒,在体内有抑制致癌物的作用:可限制肿瘤发展使其缩小甚至消除,将蒜苗和肉按4:1之比例制成馅,加10克包馅调味品,做成肉包蒸熟食用,适用于一切恶性肿瘤、白血病,并可预防肿瘤的复发和转移,每次吃350克。
6.根据权利要求1所述的治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法,其特征在于:所述的食疗方法还包括禁食抗癌疗法:
禁食疗法是指在有限的时间内,除了可以适量饮水、进食少量蔬菜汁、果汁外,禁食其它一切食物,依靠体内的能量储存保障生命活动的需要,来达到治疗或预防某些疾病的一种方法,根据禁食时间长短,可分为间歇禁食和完全禁食,间歇禁食疗法的患者每隔几天完全禁食1d,完全禁食以1周或更长的有限时间为1疗程,完全禁食必须在有条件的医院、有经验的医护人员监护下进行。
7.根据权利要求1所述的治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法,其特征在于:所述的食疗制备方法还包括心理抗癌疗法:
(1)心理支持疗法:通过家属、朋友、医生的真诚、热情的帮助,解除思想上的负担,给患者以心理上的支持,树立患者积极的生活信心;
(2)放松疗法:患者或坐、或卧,保持自然舒适的体位倾听音乐,想象自己在练习瑜伽,想象全身的癌细胞被杀死;
(3)催眠暗示疗法:应用催眠术使病人处于恍惚状态,转移患者注意力,减轻疼痛感,生物反馈疗法等多种疗法综合运用,各种疗法可以有叠加的效果,此外还可以通过使用抗焦虚药、抗抑郁药、抗精神病药物治疗手段,减轻癌症带来的的焦虚、抑郁、精神分裂症等症状;
治愈癌症的实例表明,乐观的精神与健康的心理是最好的良药,任何医疗技术与药物都无法代替精神与心理健康在治癌过程中的巨大作用,作为生物抗癌技术代表之一的CLS生物治疗法强调以生物抗癌技术为主导的同时,根据癌症患者的认知过程,影响其情绪和行为,改变癌症患者的误区,达到全面治疗患者的身心健康的目的。
8.根据权利要求1所述的治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法,其特征在于:所述的食疗制备方法还包括植物抗生素疗法:
(1)将新鲜大蒜剥除外皮,剔除杂质,捣成蒜泥;
(2)取蒜泥1000克,加入95%食用乙醇1000克,放入容器内混合后密封贮存10-15天;
(3)过滤除渣得乙蒜液1300克,加入3克维生素B1,得乙蒜混合液;
(4)将乙蒜混合液二次密封存贮3-5天即得植物抗生素,每日口服3克,每次15克。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811298210.8A CN109481589A (zh) | 2018-11-02 | 2018-11-02 | 一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811298210.8A CN109481589A (zh) | 2018-11-02 | 2018-11-02 | 一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109481589A true CN109481589A (zh) | 2019-03-19 |
Family
ID=65692166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811298210.8A Pending CN109481589A (zh) | 2018-11-02 | 2018-11-02 | 一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109481589A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110537684A (zh) * | 2019-04-23 | 2019-12-06 | 辽宁抗风竤生物医药科技有限责任公司 | 一种具有治疗肺癌食疗组合物及其制备方法 |
CN114209775A (zh) * | 2021-12-08 | 2022-03-22 | 北京御鑫堂中医研究院 | 一种治疗癌症的中药 |
CN114807039A (zh) * | 2022-06-22 | 2022-07-29 | 杭州艾名医学科技有限公司 | 一种食管癌肿瘤类器官培养用的培养基及培养方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106754A (zh) * | 2015-09-16 | 2015-12-02 | 庄树藩 | 一种食疗抗癌制剂及其制备方法 |
CN108686121A (zh) * | 2018-07-02 | 2018-10-23 | 申先元 | 一种治疗肿瘤的中药组合物 |
-
2018
- 2018-11-02 CN CN201811298210.8A patent/CN109481589A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106754A (zh) * | 2015-09-16 | 2015-12-02 | 庄树藩 | 一种食疗抗癌制剂及其制备方法 |
CN108686121A (zh) * | 2018-07-02 | 2018-10-23 | 申先元 | 一种治疗肿瘤的中药组合物 |
Non-Patent Citations (9)
Title |
---|
于泽民等: "《老年病与饮食疗法》", 30 June 1989, 工人出版社 * |
刘慧滢: "《轻松抗癌》", 30 November 2009, 黑龙江科学技术出版社 * |
吴生明: "《特级厨师教你学做:经典营养家常菜》", 28 February 2005, 内蒙古科学技术出版社 * |
李宁: "《全天然食物最养生》", 30 November 2013, 浙江科学技术出版社 * |
杨建峰: "《五谷蔬菜水果养生》", 30 April 2017, 江西科学技术出版社 * |
柴瑞霞: "《肝脏疾病吃什么?禁什么?》", 31 July 2014, 黑龙江科学技术出版社 * |
王旭东: "《中国进补大全》", 31 August 2011, 上海科学技术出版社 * |
田洪江: "《野菜养生宜忌》", 31 January 2007, 中国戏剧出版社 * |
蔡向红: "《食疗本草养生精华》", 30 June 2014, 陕西科学技术出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110537684A (zh) * | 2019-04-23 | 2019-12-06 | 辽宁抗风竤生物医药科技有限责任公司 | 一种具有治疗肺癌食疗组合物及其制备方法 |
CN114209775A (zh) * | 2021-12-08 | 2022-03-22 | 北京御鑫堂中医研究院 | 一种治疗癌症的中药 |
CN114807039A (zh) * | 2022-06-22 | 2022-07-29 | 杭州艾名医学科技有限公司 | 一种食管癌肿瘤类器官培养用的培养基及培养方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101816440B (zh) | 保健滋补油焖虾 | |
CN103141683B (zh) | 一种含中草药的复合型猪饲料 | |
CN107259571A (zh) | 一种代餐食物及其制备方法 | |
CN104770824A (zh) | 一种补气养血保健冲料 | |
CN110447902B (zh) | 一种具有减肥功效的组合物 | |
CN103417837A (zh) | 一种药食两用的枸杞养生膏及其制备方法 | |
KR20130000535A (ko) | 황토지장수를 이용한 삼계탕용 육수 및 삼계탕의 제조방법 | |
CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
CN109481589A (zh) | 一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法 | |
CN104286272A (zh) | 铁皮石斛花的用途及其茶叶制品 | |
CN106942607A (zh) | 一种用于润肠通便的组合物、含其的食疗冲料及其制备方法 | |
KR101148006B1 (ko) | 인삼 및 해삼을 포함하는 양삼계탕의 제조방법 및 그 양삼계탕 | |
CN104323217B (zh) | 一种调味白骨壤果实酱及其生产方法 | |
KR20100082689A (ko) | 월드 인삼 조성물과 그 제조방법 | |
CN105623995B (zh) | 山里红开胃酒及饮料及其制备方法 | |
KR101479228B1 (ko) | 옥수수 감자 백숙의 제조방법 및 그 백숙 | |
CN109481605A (zh) | 一种以毒攻毒治疗癌症的药物及多种抗癌疗法的制备方法 | |
KR20090057342A (ko) | 황토와 칡을 이용한 전통 종가 장류 간장 조성물과 그 제조방법 | |
CN103392855A (zh) | 健脾统血保健茶膏及制备方法 | |
CN106235009A (zh) | 一种香蒿保健锅巴 | |
CN105595190A (zh) | 一种长寿豆酱 | |
Ye et al. | Traditional Chinese dates (Jujubes)-based functional foods in Chinese history | |
CN109349562A (zh) | 一种黄精补气益脾粉及其制备方法 | |
Mercola | Upgrade Your Immunity with Herbs: Herbal Tonics, Broths, Brews, and Elixirs to Supercharge Your Immune System |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190319 |
|
RJ01 | Rejection of invention patent application after publication |